This Article Abstract Figures Only Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Gemmell, E. Articles by Seymour, G.J. Search for Related Content PubMed PubMed Citation Social Bookmarking                         What's this?

DESTRUCTIVE PERIODONTITIS LESIONS ARE DETERMINED BY THE NATURE OF THE LYMPHOCYTIC RESPONSE

¹ School of Dentistry, The University of Queensland, Brisbane 4072, Australia; and
² Faculty of Dentistry, Niigata University, Niigata 951-8514, Japan;

Correspondence: ^* corresponding author, e.gemmell{at}mailbox.uq.edu.au

CONTROVERSY The article that follows is part of an ongoing "Controversy" series. This review presents the case that destructive periodontitis is due to the nature of the lymphocytic infiltrate. In presenting this case, the authors have highlighted several controversial issues: (1) It is the inflammatory infiltrate that causes destruction and not the bacteria—that is, the lymphocytes and not the PMNs or macrophages are the primary source of destructive cytokines; (2) that susceptible subjects are characterized by the production of non-protective antibodies; and (3) that Th1 cells are associated with the stable lesion, while Th2 cells are associated with the progressive lesion. This review is intended to stimulate debate and further research, and hence may occasionally appear to be selective rather than comprehensive. —Olav Alvares, Editor, CROBM

 

Abstract

(I) Introduction

(II) Innate Immunity

(A) NEUTROPHILS IN PERIODONTAL DISEASE

(B) MACROPHAGES IN PERIODONTAL DISEASE

(III) Susceptibility to Periodontal Disease

(A) ENVIRONMENTAL FACTORS

(B) GENETIC FACTORS

(IV) Adaptive Immunity

(A) B-CELLS IN PERIODONTAL DISEASE

(B) T-CELLS IN PERIODONTAL DISEASE

(V) Animal Models

(VI) Cell-based Therapy in Periodontal Disease—Dendritic Cell Vaccines?

(VII) Conclusion

REFERENCES

	Abstract

TOP Next

Key Words: Destructive • periodontitis • lymphocytes • Th1/Th2 • cytokines

	(I) Introduction

TOP Previous Next

 
It is now generally accepted that periodontal disease results from the inflammatory response to bacteria in dental plaque. However, the innate susceptibility of the patient determines the ultimate outcome of the disease process. In other words, it is the nature of the inflammatory response which determines the destructive character of the disease. With increased bacterial challenge, bacterial products interact with the gingival epithelium to induce the expression of adhesion molecules and the production of pro-inflammatory cytokines and chemokines. Blood vessels underlying the affected epithelium show increased permeability and express adhesion molecules, and a gradient of chemoattractant signals guides leukocytes into the gingival tissues. Neutrophils migrate through the junctional epithelium and into the gingival sulcus. However, with the continued presence of bacteria, the formation of an inflammatory infiltrate in the connective tissues consisting predominantly of lymphocytes (T-cells) and macrophages takes place. Subsequently, in a susceptible person, this adaptive response still does not contain the microbial challenge leading to a change in the nature of the inflammatory response (B-cells/plasma cells) which results in either protective antibody and subsequent control of the infection or non-protective antibodies and connective tissue destruction and bone loss. Resident epithelial cells, endothelial cells, and fibroblasts respond to agents such as bacterial lipopolysaccharide (LPS), IL-1, tumor necrosis factor-alpha (TNF-), and prostaglandins, particularly PGE₂, and participate in the tissue destruction. Fibroblasts normally produce several collagens; however, in active periodontitis, the genes for collagens are turned off, as are the genes for tissue inhibitors of metalloproteinases, and the genes for matrix metalloproteinases are turned on, resulting in destruction of the extracellular matrix to make way for the increasing inflammatory cell infiltrate (reviewed in Page et al., 1997).

Page et al. (1997) have hypothesized that disease progression is due to a combination of several factors, including the presence of periodontopathic bacteria, high levels of pro-inflammatory cytokines, matrix metalloproteinases, and PGE₂, and low levels of IL-10, TGF-β, and tissue inhibitors of metalloproteinase. In this concept, it is clear that the balance of cytokines determines whether tissue destruction occurs or homeostasis is maintained (Page et al., 1997). In non-susceptible individuals, neutrophils and cell-mediated immunity will limit the extent of attachment loss. However, in susceptible individuals and in the presence of defined periodontopathic bacteria, such as Porphyromonas gingivalis, Actinobacillus actinomycetemcomitans, or Bacteroides forsythus, clearance by neutrophils will be averted and disease progression will occur. The nature of the adaptive immune response is under the control of T-cells which regulate B-cell/plasma cell differentiation and antibody production. Successful neutrophil clearance may depend upon the presence of interferon-gamma (IFN-) and may be further enhanced by protective antibodies which in turn are controlled by the types of cytokines produced by T-cells (reviewed in Page et al., 1997). Therefore, it is clear that cytokines are fundamental in determining whether periodontal disease progresses or remains stable, and the cytokines present in periodontal disease tissue are determined by the nature of the lymphocytic response.

	(II) Innate Immunity

TOP Previous Next

 
(A) NEUTROPHILS IN PERIODONTAL DISEASE
Phagocytic cells such as neutrophils and macrophages constitute the first line of defense against bacterial infection. Neutrophils have been described as playing a major role in periodontal disease (Dennison and Van Dyke, 1997), with both protective and destructive influences being suggested. Much of the evidence suggesting a protective function comes from the observation that individuals who have neutrophil disorders such as cyclic neutropenia (Cohen and Morris, 1961), Chédiak-Higashi syndrome (Hamilton and Giansanti, 1974), and leukocyte adhesion deficiency syndrome (Springer et al., 1984; Waldrop et al., 1987) have an increased susceptibility to periodontal destruction. Further, MacFarlane et al. (1992) reported significantly impaired phagocytosis due to a decreased rate of adhesion and opsonization by neutrophils from patients with refractory periodontitis compared with healthy patients. In the sulcus, neutrophils form a barrier between the epithelium and plaque (Attström and Schroeder, 1979), which may prevent bacterial invasion of the epithelium and underlying connective tissue (Hemmerle and Frank, 1991).

Neutrophils therefore can minimize the destructive effects of plaque bacteria (Dennison and Van Dyke, 1997). However, bacteria such as P. gingivalis are able to evade host innate immune responses (reviewed in Darveau et al., 1997). P. gingivalis, for example, does not stimulate the expression of the neutrophil binding adhesion molecule E-selectin on endothelial cells, thus inhibiting their migration from the circulation into the tissues. It also blocks the expression of this adhesion molecule by other Gram-negative bacteria and their LPS (Darveau et al., 1995). Inhibition of neutrophil migration into P. gingivalis-induced lesions has been demonstrated in our mouse model (Bird et al., 1995). Further, P. gingivalis-induced blocking of neutrophil transmigration through oral epithelium has been reported to be due to inhibition of epithelial cell production of the chemokine IL-8 (Madianos et al., 1997).

Bacteria including P. gingivalis produce proteases which can cleave complement and immunoglobulins, thus preventing opsonization and subsequent neutrophil killing of invading bacteria. Gingipain-R, the major arginine-specific proteinase from Porphyromonas gingivalis, has been shown to cleave a model peptide G-protein-coupled receptor found on the surface of neutrophils (Lourbakos et al., 1998). Certain strains of P. gingivalis produce enzymes which can cleave the Fc regions of bacterial-bound IgG, preventing phagocytosis, and can also cleave the C3b complement component, thereby causing evasion of neutrophil clearance (Sundqvist et al., 1984; Schenkein, 1988; Schenkein et al., 1995). Additionally, since protective antibody production enhances neutrophil clearance (Page et al., 1997), it is possible that P. gingivalis may induce antibodies with poor antibacterial properties (Slots, 1999). If the antibodies are not protective and neutrophils are inhibited, bacteria will escape clearance. A. actinomycetemcomitans also produces a protein which inhibits neutrophil chemotaxis and H₂O₂ production (Ashkenazi et al., 1992a,b). In addition, it also produces a cytolytic leukotoxin which lyses susceptible target cells, including neutrophils, monocytes, and T-cells (Taichman et al., 1980, 1991; Mangan et al., 1991). Despite this, however, the bacteria per se do not cause tissue destruction in periodontal disease. Rather, it is the nature of the inflammatory response to these bacteria that results in tissue destruction.

A regulatory role for neutrophils in periodontitis has been postulated (Seymour et al., 1993) based on the observation that they secrete a range of cytokines including IL-1 and the IL-1 receptor antagonist (Lloyd and Oppenheim, 1992). This is supported by a study which showed that peripheral blood neutrophils stimulated with a range of periodontopathic bacteria did not produce IL-1 but rather an IL-1 inhibitor, although the nature of this inhibitor was not investigated at the time (Yamazaki et al., 1989). The ability of the innate immune system to regulate the adaptive immune response via the production of cytokines such as the IL-1 receptor antagonist and IL-12 is being recognized. A strong innate immune response may, on the one hand, clear the periodontopathic bacteria and, on the other, determine the nature of the lymphocytic response, which may subsequently result in a stable or progressive form of the disease.

Controversy #1: Periodontopathic bacteria per se do not cause tissue destruction. It is the inflammatory response which leads to tissue destruction.

(B) MACROPHAGES IN PERIODONTAL DISEASE
Macrophages are important mediators of inflammation in the connective tissue infiltrate, where they produce several cytokines and also present antigens to T-cells (Dennison and Van Dyke, 1997). Activated macrophages are essential for innate resistance to intracellular infection. They produce pro-inflammatory cytokines which enhance phagocytosis and in most cases result in the successful elimination of the pathogen (Trinchieri, 1997). Complete elimination of pathogens, however, involves antigen-specific T- and B-cells. The mechanisms of innate and adaptive immune responses are hence seen to be inter-dependent (Trinchieri, 1997). Cells of the innate response influence T-cell differentiation by influencing the cytokine milieu in the tissues or draining lymph nodes where antigen-specific T-cells expand in response to antigen presentation. A high level of IL-12 during T-cell expansion will influence Th1 differentiation, while IL-4 is necessary for Th2 cells (Mosmann and Coffman, 1989; Scott, 1993).

Few studies have been reported on macrophages in periodontal disease. However, while A. actinomycetemcomitans and P. gingivalis have been shown to activate monocytes and macrophages and stimulate the secretion of pro-inflammatory and tissue-destructive mediators (Zadeh et al., 1999), a recent report has shown that there is no increase in macrophage numbers and little evidence of macrophage activation in advanced periodontitis compared with minimally inflamed tissues (Chapple et al., 1998). This is supported by reports demonstrating negative effects by periodontal pathogens on monocytes/ macrophages. For example, P. gingivalis has been shown to affect macrophage migration and activation by inhibiting the production of one of the major monocyte/macrophage chemokines, monocyte chemoattractant protein-1 (MCP-1) (Gemmell et al., 2000a). This suggests that macrophages may have protective effects in the stable lesion which are abrogated in the advanced destructive lesion. P. gingivalis, for example, has also been demonstrated to induce the production of IL-1-β in B-cells, rather than in monocytes, from periodontitis patients (Gemmell and Seymour, 1998). This suggests that the major source of IL-1 in periodontal disease may be lymphocytic rather than macrophages, further supporting the concept that destructive periodontitis is determined by the nature of the lymphocytic response.

Controversy #2: Lymphocytes rather than macrophages are the main source of destructive cytokines in periodontal disease.

	(III) Susceptibility to Periodontal Disease

TOP Previous Next

 
(A) ENVIRONMENTAL FACTORS
While periodontopathic bacteria and the inflammation they provoke are essential for disease progression, environmental risk factors such as tobacco smoking, psychosocial stress, and systemic diseases such as diabetes modify the host response and may be major determinants of the enormous variation in susceptibility (Page et al., 1997). These factors may modify the pathways by which bacteria cause inflammation and hence modify disease progression, severity, and outcome (Page et al., 1997). It is generally agreed that smoking is a risk factor for periodontal disease (Grossi et al., 1994, 1995, 1996), exerting both local and systemic effects. However, in a recent study, smoking has been shown to have little effect on disease progression but rather to have a highly significant effect on disease regression or healing, such that the increased disease expression observed in smokers is likely to be due to the inability to heal and the cumulative effect of disease over time (Faddy et al., 2000).

(B) GENETIC FACTORS
Innate susceptibility to periodontal disease is influenced by host genotype (Michalowicz, 1994). The relative contributions of genetic factors to clinical measures of periodontal disease have been studied in reared-together twins and monozygous twins reared apart (Michalowicz et al., 1991). This study suggested that from 38 to 82% of the population variance for the periodontal measures of disease could be attributed to genetic factors.

Genetic polymorphisms in Fc receptors on phagocytic cells have been suggested to be significant in determining susceptibility to bacterial infections (Sanders et al., 1995). The Fc receptor for IgG2 is FcRIIa, and individuals with low-affinity receptors have reduced IgG2-mediated phagocytosis of encapsulated bacteria and are susceptible to a variety of bacteria, including meningococcal infections (Bredius et al., 1994; Sanders et al., 1994). However, whether this is also true for individuals with chronic periodontitis has not yet been demonstrated (Page et al., 1997).

Several studies have reported a predominance of serum IgG2 antibodies in response to P. gingivalis (Lopatin and Blackburn, 1992; Whitney et al., 1992; Polak et al., 1995; Wilton et al., 1993). IgG2 antibodies are the primary immunoglobulin subclass produced in response to bacterial carbohydrates and LPS and lack strong complement fixation and opsonic properties. In periodontal disease subjects, a humoral response involving IgG2 may be ineffective in clearing P. gingivalis, depending upon the nature of the Fc receptor. One study of P. gingivalis antibodies in groups of subjects with and without periodontitis and with and without P. gingivalis infection showed that IgG2 anti-P. gingivalis antibodies were significantly higher in the group of individuals who did not have P. gingivalis in their plaque samples and did not have periodontitis, compared with individuals with P. gingivalis in their plaque (Pietrzak et al., 1998). This suggests that IgG2 antibodies may have resulted in clearance of the organism, although the Fc receptor polymorphism status of these patients was unknown.

Cytokine polymorphisms are currently receiving a great deal of attention, and there is increasing evidence that genetic variation within the TNF locus is an important factor in determining susceptibility to several diseases, including malaria, leishmaniasis, and coeliac disease (McGuire et al., 1994; Wilson et al., 1995, 1997; Manus et al., 1996). Recently, TNF genotypes of 3 bi-allelic polymorphisms were determined in adult periodontitis patients and compared with those in healthy control subjects (Galbraith et al., 1998). The level of TNF- production by oral neutrophils correlated with the TNF- 308 genotype in the periodontitis patients, with increased production found in patients with the T1,2 genotype. This association was found only in patients with advanced disease, suggesting that the TNF- genotype may be a risk factor for disease severity in periodontal disease.

Similarly, IL-1 polymorphisms have been claimed to be a risk factor for severe periodontal disease, with genotype-positive individuals having a 20 times increased risk of developing severe periodontitis after the age of 40 than those individuals who are genotype-negative (Kornman et al., 1997). The polymorphism of the composite periodontitis-associated genotype linked with expression of high levels of IL-1 has been examined in a group of periodontitis patients, with 7/22 individuals being positive for this genotype (Engebretson et al., 1999). The positive and negative groups were comparable in terms of existing periodontitis and age, and while IL-1-β levels in the gingival crevicular fluid were higher in the positive group, a reduction in IL-1-β levels after periodontal treatment occurred only in the negative group. There was also a trend toward higher IL-1-β levels in gingival biopsies of the positive group. Recently, the frequency of IL-1-β genotypes including allele 2 of the IL-1-β+3953 restriction fragment length bi-allelic polymorphism was shown to be significantly increased in patients with adult periodontitis compared with individuals with early and moderate disease (Gore et al., 1998). Further, allele 2 was associated with increased production of IL-1-β by activated peripheral blood neutrophils isolated from patients with advanced disease. In a more recent study, it was shown that the IL-1 allele 2 composite phenotype was a contributing but non-essential risk factor for periodontal disease progression over a five-year period (Cullinan et al., 2001).

Controversy #3: There is no evidence that cytokine polymorphisms are essential factors in determining the progression of periodontal disease.

	(IV) Adaptive Immunity

TOP Previous Next

 
In 1965, Brandtzaeg and Kraus demonstrated the presence of immunoglobulin-producing plasma cells in the gingival tissues of patients with periodontal disease. This was the first direct evidence that adaptive immune mechanisms may play a role in the pathogenesis of periodontal inflammation.

Ivanyi and Lehner (1970) used peripheral blood lymphocyte transformation assays to highlight a role for cell-mediated immunity in periodontal disease. Subsequently, a great many studies using a variety of lymphokine assays confirmed that cell-mediated responses did play some part in pathogenesis, but the exact role was unclear.

Direct immunohistologic investigation of the tissues throughout the 1970s and 1980s (Mackler et al., 1977; Seymour and Greenspan, 1979; Lindhe et al., 1980; Seymour et al., 1983, 1988; Reinhardt et al., 1988) seemed to confirm the hypothesis that a change from gingivitis to periodontitis involved a shift from a predominantly T-cell lesion to a B-cell/plasma cell lesion (Seymour et al., 1979). This hypothesis was also supported by functional studies, albeit using peripheral blood cells, which showed that suppressed cell-mediated immunity in advanced periodontitis subjects (Ivanyi and Lehner, 1970; Boyatzis and Seymour, 1986) could be reversed following treatment (Evans et al., 1989). Other studies also demonstrated lymphocyte suppression by periodontopathic bacteria. Low responses to P. gingivalis, Treponema denticola, and Capnocytophaga ochracea were found in both healthy and periodontitis peripheral blood lymphocytes compared with other oral bacteria (Stashenko et al., 1983), and in another study, P. gingivalis reduced the response of non-mitogen-stimulated cells (Shenker and Slots, 1989; Gemmell and Seymour, 1992). A. actinomycetemcomitans was also shown to suppress the peripheral blood lymphocyte response to mitogens (Shenker et al., 1982a), and depletion of CD8 cells was found to abrogate this response, suggesting the induction of a CD8 suppressor factor (Shenker et al., 1982b).

In terms of the transition from gingivitis to periodontitis, several studies have reported a decreased CD4/CD8 ratio (Taubman et al., 1984a; Cole et al., 1987; Stoufi et al., 1987; Okada et al., 1988; Wang et al., 1989) in periodontal lesions, while functional studies have reported a reduced autologous mixed-lymphocyte reaction (Cole et al., 1987). Taken together, these studies have suggested a local immunoregulatory imbalance. It is now generally agreed that both T- and B-cells are present in periodontal disease tissues (Zadeh et al., 1999). It is also clear that the majority of T-cells are activated memory/primed cells (Okada et al., 1988; Reinhardt et al., 1988; Takeuchi et al., 1991; Gemmell et al., 1992; Yamazaki et al., 1993). Indeed, both T- and B-cells extracted from gingival tissues have been reported to be at a more advanced stage of the cell cycle than peripheral blood T- and B-cells, indicative of activation within the tissues (Gemmell and Seymour, 1992).

(A) B-CELLS IN PERIODONTAL DISEASE
Polyclonal B-cell activation has been cited as being significant in the pathogenesis of periodontal disease. Sonic extracts of periodontopathic bacteria were first shown to induce polyclonal B-cell activation of peripheral blood lymphocytes, as assessed by the plaque-forming cell response to sheep red blood cells (Bick et al., 1981; Donaldson et al., 1982) and by the production of antibodies to several different organisms as well as specific antibody to the stimulating organism (Mangan et al., 1983; Carpenter et al., 1984). Several studies have shown that this polyclonal B-cell response to oral organisms is dependent on the presence of T-cells (Donaldson et al., 1984; Okada et al., 1987; Ito et al., 1988). While most of these studies examined peripheral blood responses, an in situ study recently reported that local proliferation of B-cells does not occur in periodontitis tissues, although plasma cells showed strong synthetic activity (Takahashi et al., 1996). However, Gemmell and Seymour (1991) previously demonstrated that B-cells extracted from periodontitis tissues do have a more activated phenotype than cells from gingivitis tissues or peripheral blood. Murine models have been used to demonstrate the induction of polyclonal B-cell activation by A. actinomycetemcomitans and P. gingivalis (Inada et al., 1994; Watanabe et al., 1996). However, when T- and B-cells from mice immunized with a 40-kDa immunodominant outer membrane antigen of P. gingivalis were examined in vitro, the secondary antibody response required the presence of B-cells, CD4+ T-cells, and H-2 restricted, Ia+ antigen-presenting cells (APC) (Oshikiri et al., 1994). The antibody response to the 40-kDa P. gingivalis antigen, therefore, was generated in an antigen-specific manner and was not the result of polyclonal B-cell activation.

The inability of specific antibodies to eliminate the causative organisms of periodontal disease could be due to several factors, including poor antigenicity of the virulence determinants and elicitation of antibodies with poor antibacterial properties (Slots, 1999). High titers of specific antibody levels to P. gingivalis (Ling et al., 1993; Wilton et al., 1993; Meghji et al., 1995) and A. actinomycetemcomitans (Saito et al., 1993; Meghji et al., 1995; Engström et al., 1999) have been reported in serum and gingival crevicular fluid, although many studies report conflicting results. Positive correlations between elevated IgG levels to P. gingivalis and A. actinomycetemcomitans have been shown in gingivitis associated with both puberty and adult periodontitis (Nakagawa et al., 1994), while a negative relationship between anti-A. actinomycetemcomitans antibodies in the serum of periodontitis patients and the burden of A. actinomycetemcomitans in infected sites has also been reported (Ebersole et al., 1994). Another study demonstrated no difference in the levels of anti-P. gingivalis antibodies in the gingival crevicular fluid of periodontitis patients and healthy control subjects, although there were moderate to strong correlations with serum antibody levels (Baranowska et al., 1989).

Serum antibody changes have been suggested to reflect the nature of the organism load (Taubman et al., 1992), and elevated levels of anti-P. gingivalis IgG antibodies have been linked to the presence of marked periodontal lesions (Gmür et al., 1986), while levels of antibodies in the gingival crevicular fluid have been cited to be an inverse of the number of organisms at the particular site of sampling (Kinane et al., 1993; Ebersole et al., 1995). Kinane et al. (1993) demonstrated a correlation of specific serum antibody titers to P. gingivalis and A. actinomycetemcomitans with mean gingival crevicular fluid titers, suggesting protective humoral immune responses, although the IgG titers to P. gingivalis in sites with higher probing depths were lower, so that patients with greater inflammation had lower IgG levels. In another group of patients, Mooney and Kinane (1997) found that anti-P. gingivalis IgG antibody levels in periodontitis sites were lower than in gingivitis sites in the same subjects, suggesting that a failure in local antibody production may contribute to the change from gingivitis to periodontitis lesions. Reinhardt et al. (1989) measured IgG subclasses in the gingival crevicular fluid of periodontally active and stable or healthy sites. The mean IgG1 and IgG4 concentrations were higher in the fluid from active periodontitis sites than in stable sites, suggesting that these antibodies were ineffective in eradicating the bacteria. At the same time, the mean levels were generally greater than in serum, especially for IgG4, further suggesting that this subclass may be a useful indicator for immunological changes which occur in active periodontal disease.

Humoral immune response studies have also focused on the determination of immunodominant antigens and a study of their functions. However, different patterns of immunoreactivity with periodontopathic bacteria have been demonstrated for A. actinomycetemcomitans (Califano et al., 1991, 1992; Engström et al., 1993; Ebersole et al., 1995) and for P. gingivalis (Curtis et al., 1991; Kurihara et al., 1991; Polak et al., 1995). Since these responses are regulated by immunoregulatory genes, it may be that antibody responses are protective in one individual but not in another (Offenbacher, 1996).

IgG subclasses and avidity have also been implicated in periodontal disease progression; however, the functional characteristics which may help to define susceptibility to the disease are still to be ascertained (Ishikawa et al., 1997). Underwood et al. (1993) suggested that high levels of anti-A. actinomycetemcomitans antibodies with high avidity may confer greater resistance to continued or repeated infection. Mooney et al. (1993) showed that patients who did not experience attachment loss during a three-month monitoring period had anti-P. gingivalis antibodies with higher avidity than those patients who did experience attachment loss. Further, Lopatin and Blackburn (1992) showed that anti-P. gingivalis and anti-P. gingivalis-LPS antibodies in periodontitis patients had significantly lower avidity than antibodies to streptokinase and tetanus toxoid, and while antibodies of the IgG1 subclass were of relatively high avidity, those in the IgG2 subclass, which were the predominant IgG subclass, were of significantly lower avidity. The relationship between titers and avidities of serum antibodies to P. gingivalis and A. actinomycetemcomitans and to clinical parameters of periodontal disease severity and the level of infection with the homologous organism has been examined in a group of periodontitis and gingivitis patients (Lamster et al., 1998). There was a negative correlation between the mean probing depths and antibody titer and avidity to A. actinomycetemcomitans and to infection with A. actinomycetemcomitans, while there was a positive correlation with respect to P. gingivalis. It was concluded that the development of an antibody response to A. actinomycetemcomitans appears to protect individuals from infection, whereas the antibody response to P. gingivalis was not able to eliminate the infection. Non-protective low-avidity anti-P. gingivalis antibodies may be incapable of effectively mediating a variety of immune responses (Lopatin and Blackburn, 1992; Whitney et al., 1992). The general inability to demonstrate immune complexes in the gingival sulcus (Clagget and Page, 1978) supports the notion that there is a compromised ability to eliminate or reduce the numbers of micro-organisms and their products from the gingival sulcus (Lopatin and Blackburn, 1992). The production of anti-P. gingivalis antibodies with different avidities in various forms of periodontal disease has been suggested to reflect the quality of the humoral response, which may affect progression of the disease (Mooney and Kinane, 1994). Wilton et al. (1993) reported that low titers to organisms such as P. gingivalis in healthy individuals were of low avidity.

The immune responses to self-antigens such as collagen type I, a major component of the periodontium, have also been suggested as a pathogenic pathway. High titers of anti-collagen type I antibody are found in the sera (Hirsch et al., 1988) and anti-collagen type I specific T-cell clones can be identified in the inflamed gingival tissues of periodontitis patients (Wassenaar et al., 1995). Sugawara et al. (1992) demonstrated that the auto-reactive CD5+ B-cells increased in periodontitis lesions and the CD5+ B-cells produced more IgM and IgG antibodies to collagen in vitro than did CD5-B-cells (Sugawara et al., 1992). Although the mechanisms that induce an immune response to self-components are not fully elucidated, molecular mimicry has been cited to explain the linkage between infection with bacteria and subsequent autoimmune mechanisms (Oldstone, 1987). Antibody responses to heat-shock protein 60 (hsp60) in particular are thought to be important. It has been reported that GroEL-like protein belonging to the hsp60 family is expressed by periodontopathic bacteria such as P. gingivalis (Hotokezaka et al., 1994; Maeda et al., 1994) and A. actinomycetemcomitans (Nakano et al., 1995), while Tabeta et al. (2000) have demonstrated that serum antibodies to P. gingivalis GroEL and human hsp60 are elevated in periodontitis patients compared with healthy control subjects (Tabeta et al., 2000). They also demonstrated that these antibodies cross-reacted with one another and concluded that the immune response to bacterial hsp60 may be an important pathogenic mechanism in periodontitis.

During the chronic phase of the disease, the antibody response has been suggested to be generally protective, to facilitate bacterial clearance, and to arrest disease progression (Offenbacher, 1996). Serum from patients with severe periodontitis containing high titers of anti-P. gingivalis antibodies completely inhibited in vitro bone resorption, whereas serum from patients with low titers failed to inhibit this bone resorption, confirming a possible protective role for specific antibodies in periodontitis (Meghji et al., 1993). Other studies suggesting a role for protective antibodies include the demonstration of anti-P. gingivalis protease antibodies which occur late in periodontitis infections and which can block the anti-opsonizing activity against C3 and IgG (Cutler et al., 1993). An increased capacity of serum to opsonize P. gingivalis has been shown to be a distinctive feature in patients with past destructive periodontal disease (Wilton et al., 1993). Opsonic IgG antibodies to A. actinomycetemcomitans which may facilitate neutrophil-mediated phagocytosis and be protective against this periodontopathic organism have also been demonstrated (Baker and Wilson, 1989; Underwood et al., 1993). Repeated infection with A. actinomycetemcomitans has been shown to elicit an anti-leukotoxin antibody which protects neutrophils from the leukocidal activity of the leukotoxin (Underwood et al., 1993). Tsai et al. (1981) showed that the majority of sera from juvenile periodontitis patients contain antibodies which neutralize A. actinomycetemcomitans leukotoxin, while sera from individuals without disease or those with other types of periodontal disease usually amplified rather than inhibited the reaction to the A. actinomycetemcomitans leukotoxin. On the other hand, however, Cutler et al. (1991) reported that only 3/17 serum samples from several adult periodontitis patients with elevated IgG to P. gingivalis A7436 were opsonic for this particular strain. In another study, antibody levels to subgingival plaque micro-organisms were found to be a predictor of bone loss in an elderly group of patients with anti-P. gingivalis antibodies to two strains of P. gingivalis having significant correlations with loss of alveolar bone (Wheeler et al., 1994).

Controversy #4: Specific antibodies produced in response to periodontopathic bacteria are protective. However, susceptible subjects are characterized by the production of non-protective antibodies.

(B) T-CELLS IN PERIODONTAL DISEASE
It would appear, therefore, that locally produced specific antibodies may be able to clear the causative organism in some people, while in others polyclonal B-cell activation and the production of low-avidity specific antibodies may not clear the infection, and disease progresses. Offenbacher (1996) suggests that if the antibody/neutrophil response does not result in clearance, the outcome of the monocyte/lymphocyte challenge is the secretion of catabolic cytokines and inflammatory mediators such as IL-1, IL-6, TNF-, and PGE₂, which induce connective tissue and bone loss. As the microbial challenge increases, and with repeated challenge, the antibody response may become protective and enable neutrophil clearance to occur, and the infection reaches homeostasis. Such a concept, however, is not in accord with the observation that the monocyte/lymphocyte infiltrate occurs early in disease formation (Page and Schroeder, 1976; Seymour et al., 1988) followed by the B-cell/plasma cell lesion which is characteristic of the advanced forms of the disease (Page and Schroeder, 1976). An alternative hypothesis, therefore, would be that failure of the innate immune response to clear the infection, even in the presence of stimulating cytokines such as IFN-, leads to the development of a B-cell/plasma cell lesion. If as a result specific antibodies with high avidity are formed, the infection is cleared and the disease does not progress. If on the other hand polyclonal B-cell activation and non-specific and/or low-avidity specific antibodies are produced, the infection is not cleared. Continued B-cell activation leads to the production of high levels of IL-1, and as a result, tissue destruction ensues. This hypothesis is consistent with the normal functioning of the immune system in bacterial infections, with the observation that B-cells are a potent source of IL-1, that macrophages are not a dominant feature of the advanced lesion, and that suppressed cell-mediated immunity is associated with advanced periodontitis.

Clearly, whichever hypothesis is correct, T-cells must play a fundamental role. T-cells are the dominant cell type in the cell-mediated (macrophage/lymphocyte) response and are necessary for both specific antibody production and polyclonal B-cell activation.

Immunohistological studies have clearly established that a T-cell/macrophage lesion identical to a delayed hypersensitivity reaction (Poulter et al., 1982) occurs within 4 to 8 days of plaque accumulation in an experimental gingivitis study (Seymour et al., 1988). This is synonymous with the early lesion of Page and Schroeder (1976) and with the putative stable lesion (Seymour et al., 1979). The expression of HLA-DR and DQ by these cells indicates that they are activated, but the lack of CD25 expression would indicate that they are not proliferating locally within the tissues (Seymour et al., 1988). The striking similarities between this early/stable periodontal lesion and delayed-type hypersensitivity prompted the suggestion that cells with a Th1 cytokine profile are the major mediator. Such a concept is consistent with the proposal that a strong innate immune response leads to the production of IL-12, which in turn leads to this Th1 response. The production of IFN- then enhances the phagocytic activity of both neutrophils and macrophages and hence containment of the infection. However, the stable lesion persists due to the continual formation of the plaque biofilm (Gemmell and Seymour, 1994).

The dominance of B-cells/plasma cells in the advanced/ progressive lesion would suggest a role for Th2 cells. Clearly, if the innate response is poor, low levels of IL-12 would be produced and a poor Th1 response may occur which may not then contain the infection. Mast cell stimulation and the subsequent production of IL-4 would encourage a Th2 response, B-cell activation, and antibody production. If as noted above these antibodies are protective and clear the infection, the disease will not progress, but if on the other hand they are non-protective, the lesion will persist, and continued B-cell activation would result in large amounts of IL-1 and hence tissue destruction (Seymour et al., 1993; Gemmell and Seymour, 1994, 1998).

To test this hypothesis, several investigators have attempted to delineate the Th1/Th2 profile in periodontal disease. However, results are difficult to interpret due to differences in material examined and methodologies used. Cytokines have been studied in cells in situ, cells extracted from gingival tissues, peripheral blood mononuclear cells, T-cell lines, and clones as well as purified cell populations. A variety of techniques has also been used, including flow cytometry, enzyme-linked immunosorbent assay (ELISA), in situ hybridization, and reverse-transcriptase/polymerase chain-reaction (RT-PCR). Additionally, bacterial components including sonicates, heat- and formalin-killed cells, outer membrane components, and purified antigens have all been used to stimulate cells in vitro, making comparisons of cytokine profiles difficult (Zadeh et al., 1999). It is likely, as indicated above, that different T-cell subsets predominate at different phases of disease, and the inability to determine disease activity clinically is a major limitation in all these studies.

Several investigators have reported decreased Th1 responses in periodontal disease (Table). Pilon et al. (1991) demonstrated lower levels of IL-2 in the gingival crevicular fluid of periodontitis sites compared with healthy sites, and Fujihashi et al. (1991) have shown that gingival mononuclear cells from adult periodontitis patients produce IL-4 and IL-5 but not IL-2. Peripheral blood mononuclear cells from periodontitis patients stimulated with mitogens resulted in reduced IFN- secretion and mRNA expression of IFN- and IL-2. At the same time, significantly higher levels of IL-5 and GM-CSF were observed (Sigusch et al., 1998). Significantly less IL-2 activity was also found in peripheral blood mononuclear cell cultures stimulated with P. gingivalis and another oral Gram-negative anaerobe, Fusobacterium nucleatum, compared with unstimulated cultures (Gemmell and Seymour, 1994). In this study, IFN- as measured by an ELISA could not be detected in cultures containing both bacteria; furthermore, IFN- was demonstrated in only 10/27 gingival mononuclear cell culture supernatants. A recent in vivo study has confirmed these observations, showing that priming of mice with F. nucleatum prior to challenge with P. gingivalis resulted in a polarized Th2 response, while P. gingivalis alone resulted in a Th1 response (Choi et al., 2000). This important paper highlights the complexities involved in periodontal disease and the dangers of using single organisms in highly artificial settings.

In contrast to these studies, Ebersole and Taubman (1994) found that IFN- message was prominently expressed by diseased gingival tissue cells (Table). Cytokine profiles of cells extracted from six patients were consistent with Th1 cells in that they were IL-2- and IFN--positive but negative for IL-4 and IL-5. A further sample had message for IL-2 and IL-5, consistent with Th0 cells. The investigators' inability to detect IL-4 mRNA in these experiments could have been due to its very short half-life rather than to its absence from the tissues. As with other studies, disease activity was not clearly defined, such that, again, interpretation is difficult. Another study comparing the local and systemic responses in periodontitis patients with so-called terminal dentition periodontitis demonstrated reduced Th2 responses. Levels of PGE₂, IL-1-β, and IL-2 in the gingival crevicular fluid samples were highest, followed by lower levels of TNF- and IFN- and even lower levels of IL-4 and IL-6 (Salvi et al., 1998) (Table). LPS-stimulated monocytes from these patients resulted in significantly elevated levels of PGE₂, IL-1-β, and TNF- compared with cultures of cells derived from control subjects with moderate to advanced disease. Cytokine mRNA expression of Th1 and Th2 cytokines was present in isolated gingival mononuclear cells with low levels of IL-4 and IL-12. While it was concluded that Th1 cytokine levels dominated over the Th2 response in the gingival crevicular samples, and that monocyte activation provided the major source of pro-inflammatory mediators, because different concentrations of different cytokines result in different levels of biological activity, the comparison of different levels of cytokines in the same patient is inappropriate. It would have been of greater value had the levels of the same cytokines been compared in patients from different disease groups. Equally, the ability of peripheral blood monocytes to produce cytokines upon stimulation does not imply that these are the major source of these cytokines in a highly localized lesion as is seen in periodontal disease. Interpretation of this study is therefore difficult.

Other studies have suggested the involvement of Th0 cells in periodontal disease (Table). Fujihashi et al. (1994) extracted mRNA for IFN-, IL-6, and IL-13, but not for IL-2, IL-4, or IL-5 in CD4+ T-cells from periodontal disease lesions. Takeichi et al. (1994) showed that IFN- and IL-1-β mRNA was expressed by some gingival cells on extraction, indicative of Type 1 cells, and upon stimulation, IL-6 transcripts were also expressed but no IL-2 or IL-2 receptor mRNA could be detected. Yet another study found no skewing of cytokines toward a Th1 or Th2 profile in diseased or healthy tissues, although there was a significantly higher expression of IL-6 and IFN- mRNA in diseased tissues (Prabhu et al., 1996). Fujihashi et al. (1996) isolated CD4 cells from inflamed gingival tissues and demonstrated two profiles, both of which were positive for IFN-, IL-6, and IL-13 mRNA, while one group and not the other was also positive for IL-10. Nakajima et al. (1999) demonstrated that stimulation of peripheral blood mononuclear cells from individuals with periodontitis and gingivitis with P. gingivalis resulted in up-regulation of messenger RNA for IFN- and IL-13, while IL-4 and IL-10 were down-regulated, regardless of disease status or the presence of P. gingivalis in plaque samples. Message for several cytokines has been compared in the gingival tissues and peripheral blood of periodontitis patients (Yamazaki et al., 1997). The mean expression of IFN- mRNA was higher in the peripheral circulation than in the gingival tissues, while that of IL-10 mRNA was higher in the gingival tissues. However, only 7/16 samples demonstrated a high expression of IL-10, the other samples showing equivalent levels in blood and tissues. IL-12 mRNA was similarly expressed to a higher extent in 6/16 samples, the other samples showing no differences between gingiva and peripheral blood. IL-4 mRNA was weak but detectable in only 3 samples.

Studies on T-cell lines and clones have also demonstrated conflicting results (Table). One such study reported that T-cell lines and clones specific for P. gingivalis resembled Th0 cells, although one CD4+ clone did produce IL-4 and IL-5 mRNA, suggesting a Th2 profile (Karatzas et al., 1996). Flow cytometry and RT-PCR have been used to show that CD4 and CD8 cells in P. gingivalis-specific lines and clones derived from a P. gingivalis-positive gingivitis subject and a P. gingivalis-positive periodontitis patient produced IL-4, IL-10, and IFN- (Gemmell et al., 1995). However, in a further study, several lines established from P. gingivalis-positive gingivitis and periodontitis subjects demonstrated highly variable profiles, although the mean results showed that a high percentage of both CD4 and CD8 cells was positive for IFN-, with lower percentages of IL-4+ and IFN-+ cells. Lines established from the periodontitis subjects demonstrated more variation than lines from the gingivitis individuals, such that IL-4+ and/or IL-10+ T-cells predominated over IFN-+ cells in a greater number of lines (Gemmell et al., 1999). Wassenaar et al. (1995) established T-cell clones from the gingival tissues of four patients with chronic periodontitis, although these were raised non-specifically with the use of mitogen and IL-2. Eighty percent of the CD4 clones had Th2 phenotypes producing high levels of IL-4 and low levels of IFN-, while the majority of CD8 clones demonstrated a Th0-like pattern producing equal amounts of IL-4 and IFN-. A further study demonstrated two subsets of CD8 clones expressing the β T-cell receptor, one of which produced high levels of IFN- but no IL-4 or IL-5 (Th1) and mediated cytolytic activity, while the other subset produced high levels of IL-4 together with IL-5 and displayed no cytotoxicity. The latter Th2 cells suppressed the proliferative response of cytotoxic CD8 T-cell clones, which could be abolished by the addition of anti-IL-4 antibodies, although IL-4 alone could not induce this suppression. Therefore, CD8 T-cells may participate in the local response by suppressing IFN--producing cells and favoring humoral immune responses (Wassenaar et al., 1996). While it is difficult to interpret all these studies, the pattern seems to be emerging that within the tissue, gingivitis seems to be associated with a Th1 response, while periodontitis is associated with a Th2 response. This is consistent with the histology of these two diseases. In peripheral blood, however, no clear pattern is emerging. The reasons for this remain obscure.

Emanating from studies of cytokines in periodontal disease is the concept that IL-10 may be of fundamental importance in the control of periodontal disease progression. A significant decrease in the percent of IL-10+ CD8 cells in gingival cells extracted from periodontitis tissues in comparison with gingivitis samples has been demonstrated (Gemmell and Seymour, 1998), although Stein and Hendrix (1996) found that gingival mononuclear cells extracted from adult periodontitis patients produced more IL-10 than cells derived from non-inflamed tissue. As well, anti-IL-10 antibodies induced an 80% decrease in the frequency of anti-collagen-secreting cells, and it was suggested that IL-10 in inflamed gingival tissues potentiates a local autoimmune response characterized by an increase in anti-collagen-secreting cell frequency. A role for IL-10 has been suggested by another study which analyzed cytokine expression in CD4+ gingival lymphocytes isolated from inflamed periodontal tissues. As reported by Fujihashi et al. (1996), two distinct profiles were noted. One pattern showed the presence of IFN-, IL-6, IL-10, and IL-13 mRNA, while the other pattern was similar with the exception of a lack of IL-10 mRNA. In most cases, IL-2, IL-4, and IL-5 mRNA were not detected (Yamamoto et al., 1997). IL-10 has been demonstrated to inhibit LPS-induced B-cell proliferation in the mouse (Marcelletti, 1996), and decreased IL-10 in periodontitis may possibly allow for continued polyclonal B-cell activation.

Studies on cytokines have led to the formulation of several hypotheses as to which T-cell subsets are associated with periodontitis. Seymour et al. (1993) proposed that due to the shift in lymphocyte populations in the inflammatory infiltrate from predominantly T-cells in gingivitis to an increased proportion of B-cells in periodontitis, susceptibility to periodontal disease progression may involve a predominantly Th2-like response in which T-cells produce the cytokines required for B-cell proliferation and differentiation, leading to polyclonal B-cell activation, the production of elevated levels of non-protective antibodies, and the continued production of B-cell IL-1. Non-susceptibility to periodontal breakdown may involve a predominantly Th1-like response, resulting in T-cell activation, cell-mediated immunity, IFN- enhancement of innate immunity, and, if necessary, the production of protective antibodies (Fig., A). On the other hand, Ebersole and Taubman (1994) have formulated their hypothesis (Fig., B) based on their adoptive transfer experiments using the Th2 clone A3. They speculate that Th2 cells abrogate periodontal disease symptoms and Th1 cells enhance disease. Th2 cells could be protective, providing help for specific antibody production which they propose is a key feature of protection against periodontal destruction, while Th1 and CD8+ cells may be destructive via the production of IFN- and potential stimulation of macrophage IL-1, leading to bone destruction. Th1 cells therefore exert pro-inflammatory effects leading to tissue injury and immunopathology, while Th2 cells produce cytokines leading to anti-inflammatory functions (IL-4 and IL-10 down-regulate IL-1 production [Essner et al., 1989] and IL-10 increases IL-1 receptor antagonist secretion [Schreiber et al., 1995]) and the down-regulation of Th1 cell-mediated tissue-destroying effects (Del Prete et al., 1993).

View larger version (24K): [in this window] [in a new window]   Figure. Models for the roles of Th1 and Th2 cytokines in periodontal disease progression as proposed by (A) Seymour et al. (1993), (B) Ebersole and Taubman (1994), and (C) Dennison and Van Dyke (1997).

Overall, this hypothesis is not consistent with the observation that relatively few macrophages are present in those advanced lesions showing the most tissue destruction (Chapple et al., 1998). If this hypothesis was correct, one would reasonably expect to find the most numbers of macrophages where the tissue destruction was greatest. The lack of macrophages in these advanced lesions, however, is consistent with the presence of IL-4 (and/or IL-13) and hence of a Th2 response. The source of IL-1 remains to be determined, but again, B-cells would seem to be implicated (Gemmell and Seymour, 1998).

Controversy #5: Th1 cells are associated with the stable lesion, while Th2 cells are associated with the progressive lesion in humans.

	(V) Animal Models

TOP Previous Next

 
Investigators have used animal models to try to obtain a clearer picture of the pathogenesis of periodontal disease, which can often be obscured in studies on humans because of the difficulty in diagnosing susceptible and non-susceptible individuals, of determining disease activity, and because of the different bacterial complexes involved in different people. Animal model studies have provided important information toward building a picture of periodontopathic bacteria-mediated response, particularly the responses to P. gingivalis and A. actinomycetemcomitans, but their extrapolation to human disease always remains speculative.

Several investigators have reported on the effects of immunization of non-human primates with P. gingivalis. Anderson et al. (1995) demonstrated the production of an antibody response which enhanced neutrophil phagocytosis of P. gingivalis. However, an enormous variability in the functional capacity of the serum samples was noted, suggesting that antibody function may be a poor predictor of susceptibility to disease. Another study using Macaca fascicularis demonstrated inhibition of the progression of periodontal tissue destruction (Persson et al., 1994). Immunization with a purified P. gingivalis cysteine protease induced a significantly elevated specific IgG response and fewer alveolar bone density changes compared with sham-immunized control animals (Moritz et al., 1998). However, immunization of these animals with combined P. gingivalis and Prevotella intermedia resulted in significantly greater bone density loss in ligated teeth compared with control animals, so that mixed-bacterial immunization resulted in increased disease (Ebersole et al., 1991). This model has also shown that on the induction of experimental disease, the front of inflammatory cells progresses toward alveolar bone, with associated osteoclast formation (Graves et al., 1998). When IL-1 and TNF- activity was blocked by local injection of soluble receptors to these cytokines, the progression of the inflammatory cells was inhibited, suggesting that this activity was at least partly dependent on IL-1 and/or TNF-.

Rodent models have been used extensively to study the immune responses to periodontopathic bacteria or their products, including LPS. Early studies demonstrated that LPS from P. gingivalis strains induced marked mitogenic responses and polyclonal B-cell activation in spleen cells, activated both neutrophils and macrophages, and enhanced IL-1 production by murine peritoneal macrophages (Fujiwara et al., 1988; Isogai et al., 1988). However, Kesavalu et al. (1992) found that immunization with whole cells or LPS of P. gingivalis provided no protection against the lethal effects after challenge with LPS. Additionally, Chen et al. (1990) demonstrated that immunization of mice with P. gingivalis LPS did not result in readily detectable IgG or IgM levels to LPS, nor did it reduce the severity of P. gingivalis infection. Taken together, these results suggest that responses to LPS may not be protective, and that a response to these antigens may not prevent progression of disease.

Immunization with whole cells of P. gingivalis, on the other hand, has been shown to elicit protection in the form of faster healing of lesions and production of specific antibodies (Chen et al., 1990; Genco et al., 1992; Kesavalu et al., 1992). Kesavalu et al. (1992) demonstrated that this protection was primarily due to opsonic antibodies, resulting in phagocytic destruction of virulence components. Using 4 strains of inbred mice, Gemmell et al. (2000b) demonstrated that anti-P. gingivalis antibody levels correlated with lesion recovery after challenge with P. gingivalis.

Synthetic peptides of P. gingivalis fimbriae have been reported to induce both Th1 and Th2 cytokines in vitro with the use of in vivo primed mouse T-cells (Deslauriers et al., 1996). Further, mice immunized with recombinant fimbrillin and 2 synthetic peptides induced specific antibodies to fimbrillin, and immunization with one of the peptides, PgF-P8, protected against a lethal injection of P. gingivalis, although the degree of protection depended on the time of immunization before challenge. However, no correlation could be found between protection and in vivo local cytokine production, specific antibody levels, or the isotype of the anti-PgF-p8 antibodies produced (Deslauriers et al., 1996).

Responses of mice to co-infection have been reported. Mice infected with P. gingivalis together with F. nucleatum had significantly greater skin lesions than those infected with P. gingivalis alone, while active immunization with P. gingivalis protected against challenge with both organisms (Ebersole et al., 1997). Protection in this study correlated with levels of specific serum antibodies. Chen et al. (1996) reported that immunization of A. actinomycetemcomitans together with P. gingivalis resulted in first- and second-degree lesions compared with first-degree lesions only, which followed immunization with A. actinomycetemcomitans alone. The serum anti-P. gingivalis response was higher in mice injected with both organisms than in P. gingivalis-only-injected mice, although this was not observed with the anti-A. actinomycetemcomitans antibody response. As previously mentioned, Choi et al. (2000) have shown that immunization with F. nucleatum followed by challenge with P. gingivalis leads to a polarized Th2 response, whereas immunization with P. gingivalis alone leads to a Th1 response. Gemmell et al. (1998) have previously shown a predominant splenic Th1 response with high percentages of IFN--positive T-cells following immunization with a high dose of P. gingivalis outer membrane antigens. These studies again highlight the complex, often synergistic, responses (Ebersole et al., 1991) with co-infection, which may have relevance to the multibacterial infection of human periodontal disease.

The influence of T-cells on periodontal bone destruction induced by endotoxin was reported in a study showing that repeated injections of Escherichia coli endotoxin into the gingiva of mice mandibles increased bone resorption in normal as well as T-cell reconstituted nude mice compared with nude mice (Ukai et al., 1996). The effects of P. gingivalis were demonstrated by Baker et al. (1994, 1999), who infected the mouths of immunocompetent mice with P. gingivalis, resulting in increased levels of specific antibody and significant bone loss. Infected severe combined immunodeficient (SCID) mice (lacking T- and B-cells) also demonstrated bone loss, although not to the same extent as immunocompetent mice. These studies support the contention that tissue destruction and bone loss in periodontal disease are determined by the lymphocytic infiltrate. In another study, T-cells derived from the spleen or Peyer's patches of normal Fischer rats after oral inoculation with P. gingivalis were adoptively transferred into nude Fischer rats. After oral challenge with live organisms, serum and salivary responses were noted in treated nude rats compared with control rats which did not receive T-cells, indicating a T-cell-dependent response to P. gingivalis. Splenic and Peyer's patch T-cells induced different responses with higher serum IgG, especially IgG2 induced by the former cells, although salivary IgA responses were similar. Less horizontal bone loss was seen in rats adoptively transferred with spleen T-cells. IgG2 responses indicate the involvement of Th1 cells with IgA, the involvement of Th2 cells suggesting that the balance between these T-cell subsets may determine whether the reponses are protective against experimental bone loss after oral challenge to P. gingivalis (Katz and Michalek, 1998).

The role of the immune response to A. actinomycetemcomitans has also been studied in rats. Taubman et al. (1984b) first showed that immunization with A. actinomycetemcomitans induced a delayed-type hypersensitivity reaction with elevated bone loss compared with sham-immunized rats. Furthermore, athymic nude rats demonstrated more bone loss than normal littermates, although bone loss in nude rats reconstituted with thymus cells was similar to that in control rats. It was concluded that T-cells can exert protective and/or destructive effects on periodontal destruction. When cells from an A. actinomycetemcomitans-specific T-cell clone (A3) were adoptively transferred into rats followed by oral infection with A. actinomycetemcomitans, significantly elevated IgG and IgM antibodies to A. actinomycetemcomitans were found, and bone loss was significantly lower than in rats which did not receive the T-cells but were orally infected with the organisms (Yamashita et al., 1991). In this study, T-cells appeared to interfere with periodontal bone loss. Recently, gingival injection of A. actinomycetemcomitans was demonstrated to induce local bone resorption in rats after the transfer of A. actinomycetemcomitans-specific Th1 clone cells but not after the transfer of Th2 cells (Kawai et al., 2000). The clone cells were retained in the gingival tissues for up to 3 days. A. actinomycetemcomitans LPS was required for this bone resorption and for A. actinomycetemcomitans-specific IgG2 production. LPS also elicited the expression of B7-1 and B7-2 molecules on gingival macrophages. The administration of CTLA4Ig, which is a functional antagonist of CD28/B7 binding, abrogated the bone resorption induced by Th1 clone cells after challenge with A. actinomycetemcomitans and LPS. The results suggested that local antigen-specific activation of Th1-type cells by B7 co-stimulation may trigger inflammatory bone resorption. The relevance of these findings to human periodontal disease, however, remains to be determined.

	(VI) Cell-based Therapy in Periodontal Disease—Dendritic Cell Vaccines?

TOP Previous Next

 
If the hypothesis that Th1 cells are associated with the stable lesion and Th2 cells are associated with the progressive lesion is true, it would follow that therapies aimed at enhancing a Th1 profile may have some role in the treatment of advanced or even refractory periodontal disease. In this context, therefore, control of the Th1/Th2 profile would be fundamental. APC differ in their abilities to induce activation of different T-cell subsets and hence the cytokine profiles induced (Sundstrom and Ansari, 1995). Dendritic cells are professional APC which have an extraordinary capacity for initiating primary and secondary T-cell responses (Steinman, 1991). Immature dendritic cells originate in the bone marrow and migrate to peripheral non-lymphoid tissues. Dendritic cells process antigen and can also recruit leukocytes to the site of inflammation by the production of chemokines, inflammatory cytokines, and interferons. In the presence of inflammatory signals such as LPS, IL-1, TNF-, they differentiate, and a switch in chemokine receptor expression allows them to migrate from mucosal surfaces as veiled cells via the afferent lymph to the draining lymph nodes. During this process, dendritic cells down-regulate their ability to phagocytose and process antigen and up-regulate MHC class I and II molecules and the co-stimulatory molecules CD80, CD86, and CD40 and present antigen to T-cells in the T-cell areas (Pettit and Thomas, 1999; Rescigno et al., 1999). Activated T-cells in the lymph nodes may then activate B-cells. Follicular dendritic cells in the germinal follicles can stimulate memory B-cells which in turn stimulate further T-cell activity. Memory T-cells travel to the site of inflammation and can be activated at the peripheral sites. Memory T-cells can also travel via the afferent lymph back to the lymph nodes, and B-cells can carry antigen into the nodes from the circulation (Knight and Stagg, 1993).

T-cells in the gingival tissues are primed/memory cells (Gemmell et al., 1992; Yamazaki et al., 1993), and in the development of periodontal disease, plaque bacterial antigens are most likely initially presented to T-cells in the regional lymph nodes, after which sensitized T-cells home back to the gingival tissues, where they are further activated (Seymour et al., 1988). Higher numbers of CD1+ Langerhans cells have been demonstrated in the epithelium of marginal gingivitis and adult periodontitis than in healthy tissues (Meng and Zheng, 1990), and increasing numbers were shown in a 21-day experimental gingivitis study (Seymour et al., 1988). In this study, adenosine triphosphatase+ cells with a morphology typical of interdigitating dendritic cells were also demonstrated in the perivascular spaces in close contact with lymphocytes, although approximately four times as many acid phosphatase+ phagocytic macrophages were present within the lesions as well as in the subepithelial zones. Increasing numbers of B-cells express an increasingly activated phenotype in the progression from gingivitis to periodontitis (Gemmell and Seymour, 1991), while macrophage numbers do not increase in advanced periodontitis compared with minimally inflamed tissues (Chapple et al., 1998). The roles of dendritic cells, B-cells, and macrophages as APC in periodontitis have not yet been elucidated. However, unlike B-cells, macrophages and dendritic cells both bind antigen by relatively non-specific mechanisms. Macrophages and dendritic cells may therefore provide signals that initially activate T-cells, while B-cell antigen presentation may allow for further activation and clonal expansion of these already-activated cells.

Non-professional APC may initiate secondary immune responses after the induction of MHC class II molecules by cytokines such as IFN- (Nickoloff and Turka, 1994). Gingival keratinocytes contribute to periodontal disease progression by the secretion of several pro-inflammatory cytokines, including IL-1, IL-6, and IL-8, and the expression of adhesion molecules, which aid in the influx of leukocytes into the gingival sulcus. Epithelial tissues act as physical barriers to the outside environment; however, unlike normal plaque flora, the periodontopathogens P. gingivalis and A. actinomycetemcomitans can disrupt the gingival epithelial barrier by adhering to and invading epithelial cells and even the connective tissues in diseased sites (Sandros et al., 1993; Fives-Taylor et al., 1995), highlighting the possibility of antigen presentation of P. gingivalis and A. actinomycetemcomitans antigens by gingival keratinocytes (Saglie et al., 1988). Keratinocytes function as accessory cells by activating T-cells via the TCR/CD3 complex, and this involves signals by the adhesion molecules ICAM-1 (CD54) on the keratinocyte and LFA-1 (CD11a) on the T-cell (Nickoloff et al., 1993). Approximately 50% of cells in the infiltrates of periodontal lesions have been shown to be LFA-1+ while keratinocytes in inflamed gingiva express HLA-DR, ICAM-1, and LECAM-1 (CD62L) (Gemmell et al., 1994). As well as keratinocytes, other resident cells such as activated endothelial cells and fibroblasts may also play a role in antigen presentation in periodontitis lesions.

Suchett-Kaye et al. (1998) have suggested that T-cells in the progressive lesion may respond to a wider range of APC, including gingival keratinocytes, leading to dysregulation of the T-cell response, particularly cell-mediated immunity, as well as favoring non-protective polyclonal B-cell responses. In the study alluded to earlier, peripheral blood mononuclear cells were used as APC to present P. gingivalis antigens to P. gingivalis-specific T-cells, resulting in highly varied profiles, due possibly to presentation by dendritic cells and/or monocytes and/or B-cells (Gemmell et al., 1999). While these results were inconclusive, we have recently been able to demonstrate that when these same lines were presented with P. gingivalis antigens by autologous EBV-transformed B-cells (LCL), the cytokine profiles were predominantly IL-4+, with lower numbers of IFN-+ T-cells and very few IL-10+ T-cells, and these profiles were constant for every T-cell line. These results strongly suggest a central role for APC in periodontal disease.

While the function of different APC in periodontitis is mostly purely speculative, Cutler et al. (1999) have recently put forward a hypothesis on dendritic cells and P. gingivalis based on their observations of in vivo and in vitro events. P. gingivalis was identified in the epithelium and connective tissues of gingival sections from periodontitis subjects, and double immunofluorescence showed an association between P. gingivalis and immature CD1a+ Langerhans cells in the epithelium. Immature dendritic cells appeared to be limited to the epithelium, whereas mature dendritic cells were restricted to the connective tissue. It was hypothesized that immature dendritic cells could be exposed to P. gingivalis, resulting in their activation/maturation and movement into the connective tissue. In vitro evidence that dendritic cells internalize P. gingivalis was demonstrated. As well, maturation of the dendritic cells was shown by increased expression of co-stimulatory molecules, CD83 and HLA-DR. Sensitized dendritic cells were also able to stimulate T-cells to proliferate in a dose-dependent manner. P. gingivalis sensitization of dendritic cells was further hypothesized to occur in advanced gingivitis or early active periodontitis, followed by the homing of P. gingivalis-specific effector T-cells with persistent P. gingivalis infection in severe periodontitis.

In the future, appropriate APC may be used to modulate the immune response to induce protective responses in susceptible people. The use of dendritic cells as a powerful tool for manipulating the immune system is currently being examined in several areas. In particular, dendritic cells have been shown to be potent immunotherapeutic agents when pulsed with tumor-associated antigens, and trials based on their use as an effective anti-cancer treatment (Hart, 1997) are currently being conducted. Whether dendritic cells pulsed with protective antigens of periodontopathic bacteria will be an appropriate form of treatment has yet to be determined.

	(VII) Conclusion

TOP Previous Next

 
This review, as part of the "Controversy" series, has highlighted several controversial issues related to our current knowledge of the pathogenesis of periodontal disease. The review is intended to be provocative, to stimulate debate, and, importantly, to stimulate further research. In a true Popperian sense, science advances by the formation of models or hypotheses and by experiments being designed to disprove these hypotheses. In this context, if this review stimulates further research, it will have achieved its aim.

REFERENCES

TOP

• Anderson DM, Ebersole JL, Novak MJ (1995). Functional properties of nonhuman primate antibody to Porphyromonas gingivalis. Infect Immun 63:3245–3252.[Abstract]
• Aoyagi T, Sugawara-Aoyagi M, Yamazaki K, Hara K (1995). Interleukin 4 (IL-4) and IL-6-producing memory T-cells in peripheral blood and gingival tissues in periodontitis patients with high serum antibody titers to Porphyromonas gingivalis. Oral Microbiol Immunol 10:304–310.[Medline] [Order article via Infotrieve]
• Ashkenazi M, White RR, Dennison DK (1992a). Neutrophil modulation by Actinobacillus actinomycetemcomitans. I. Chemotaxis, surface receptor expression and F-actin polymerization. J Periodontal Res 27(4 Pt 1):264–273.[Medline] [Order article via Infotrieve]
• Ashkenazi M, White RR, Dennison DK (1992b). Neutrophil modulation by Actinobacillus actinomycetemcomitans. II. Phagocytosis and development of respiratory burst. J Periodontal Res 27:457–465.[CrossRef][Medline] [Order article via Infotrieve]
• Attström R, Schroeder HE (1979). Effect of experimental neutropenia on initial gingivitis in dogs. Scand J Dent Res 87:7–23.[Medline] [Order article via Infotrieve]
• Baker PJ, Wilson ME (1989). Opsonic IgG antibody against Actinobacillus actinomycetemcomitans in localized juvenile periodontitis. Oral Microbiol Immunol 4:98–105.[Medline] [Order article via Infotrieve]
• Baker PJ, Evans RT, Roopenian DC (1994). Oral infection with Porphyromonas gingivalis and induced alveolar bone loss in immunocompetent and severe combined immunodeficient mice. Arch Oral Biol 39:1035–1040.[CrossRef][Medline] [Order article via Infotrieve]
• Baker PJ, Dixon M, Evans RT, Dufour L, Johnson E, Roopenian DC (1999). CD4(+) T cells and the proinflammatory cytokines gamma interferon and interleukin-6 contribute to alveolar bone loss in mice. Infect Immun 67:2804–2809.[Abstract/Free Full Text]
• Baranowska HI, Palmer RM, Wilson RF (1989). A comparison of antibody levels to Bacteroides gingivalis in serum and crevicular fluid from patients with untreated periodontitis. Oral Microbiol Immunol 4:173–175.[Medline] [Order article via Infotrieve]
• Bick PH, Carpenter AB, Holdeman LV, Miller GA, Ranney RR, Palcanis KG, et al. (1981). Polyclonal B-cell activation induced by extracts of Gram-negative bacteria isolated from periodontally diseased sites. Infect Immun 34:43–49.[Abstract/Free Full Text]
• Bird PS, Gemmell E, Polak B, Paton RG, Sosroseno W, Seymour GJ (1995). Protective immunity to Porphyromonas gingivalis infection in a murine model. J Periodontol 66:351–362.[Medline] [Order article via Infotrieve]
• Boyatzis S, Seymour GJ (1986). Effect of age and periodontal disease status in man on the spontaneous proliferation of peripheral blood lymphocytes. Arch Oral Biol 31:749–755.[Medline] [Order article via Infotrieve]
• Brandtzaeg P, Kraus FW (1965). Autoimmunity and periodontal disease. Odontology 73:285–393.
• Bredius RG, Derkx BH, Fijen CA, de-Wit TP, de Haas M, Weening RS, et al. (1994). Fc gamma receptor IIa (CD32) polymorphism in fulminant meningococcal septic shock in children. J Infect Dis 170:848–853.[Medline] [Order article via Infotrieve]
• Califano JV, Schenkein HA, Tew JG (1991). Immunodominant antigens of Actinobacillus actinomycetemcomitans serotypes a and c in high-responder patients. Oral Microbiol Immunol 6:228–235.[Medline] [Order article via Infotrieve]
• Califano JV, Schenkein HA, Tew JG (1992). Immunodominant antigens of Actinobacillus actinomycetemcomitans serotype b in early-onset periodontitis patients. Oral Microbiol Immunol 7:65–70.[Medline] [Order article via Infotrieve]
• Carpenter AB, Sully EC, Ranney RR, Bick PH (1984). T-cell regulation of polyclonal B cell activation induced by extracts of oral bacteria associated with periodontal diseases. Infect Immun 43:326–336.[Abstract/Free Full Text]
• Chapple CC, Srivastava M, Hunter N (1998). Failure of macrophage activation in destructive periodontal disease. J Pathol 186:281–286.[CrossRef][Medline] [Order article via Infotrieve]
• Chen PB, Davern LB, Schifferle R, Zambon JJ (1990). Protective immunization against experimental Bacteroides (Porphyromonas) gingivalis infection. Infect Immun 58:3394–3400.[Abstract/Free Full Text]
• Chen PB, Davern LB, Katz J, Eldridge JH, Michalek SM (1996). Host responses induced by Porphyromonas gingivalis and Actinobacillus actinomycetemcomitans in a murine model. Oral Microbiol Immunol 11:274–281.[Medline] [Order article via Infotrieve]
• Choi JI, Borrello MA, Smith ES, Zauderer M (2000). Polarization of Porphyromonas gingivalis-specific helper T-cell subsets by prior immunization with Fusobacterium nucleatum. Oral Microbiol Immunol 15:181–187.[Medline] [Order article via Infotrieve]
• Clagget JA, Page RC (1978). Insoluble immune complexes and chronic periodontal diseases in man and the dog. Arch Oral Biol 23:153–165.[CrossRef][Medline] [Order article via Infotrieve]
• Cohen DW, Morris AL (1961). Periodontal manifestation of cyclic neutropenia. J Periodontol 32:159–168.
• Cole KC, Seymour GJ, Powell RN (1987). Phenotypic and functional analysis of T cells extracted from chronically inflamed human periodontal tissues. J Periodontol 58:569–573.[Medline] [Order article via Infotrieve]
• Corcoran ML, Stetler-Stevenson WG, Brown PD, Wahl LM (1992). Interleukin 4 inhibition of prostaglandin E₂ synthesis blocks interstitial collagenase and 92-kDa type IV collagenase/gelatinase production by human monocytes. J Biol Chem 267:515–519.[Abstract/Free Full Text]
• Cullinan MP, Westerman B, Hamlet SM, Palmer JE, Faddy MJ, Lang NP, et al. (2001). A longitudinal study of interleukin-1 gene polymorphisms and periodontal disease in a general adult population. J Clin Periodontol 28:1137–1144.[CrossRef][Medline] [Order article via Infotrieve]
• Curtis MA, Slaney JM, Carman RJ, Johnson NW (1991). Identification of the major surface protein antigens of Porphyromonas gingivalis using IgG antibody reactivity of periodontal case-control serum. Oral Microbiol Immunol 6:321–326.[Medline] [Order article via Infotrieve]
• Cutler CW, Kalmar JR, Arnold RR (1991). Phagocytosis of virulent Porphyromonas gingivalis by human polymorphonuclear leukocytes requires specific immunoglobulin G. Infect Immun 59:2097–2104.[Abstract/Free Full Text]
• Cutler CW, Arnold RR, Schenkein HA (1993). Inhibition of C3 and IgG proteolysis enhances phagocytosis of Porphyromonas gingivalis. J Immunol 151:7016–7029.
• Cutler CW, Jotwani R, Palucka KA, Davoust J, Bell D, Banchereau J (1999). Evidence and a novel hypothesis for the role of dendritic cells and Porphyromonas gingivalis in adult periodontitis. J Periodontal Res 34:406–412.[CrossRef][Medline] [Order article via Infotrieve]
• Darveau RP, Cunningham MD, Bailey T, Seachord C, Ratcliffe K, Bainbridge B, et al. (1995). Ability of bacteria associated with chronic inflammatory disease to stimulate E-selectin expression and promote neutrophil adhesion. Infect Immun 63:1311–1317.[Abstract]
• Darveau RP, Tanner A, Page RC (1997). The microbial challenge in periodontitis. Periodontol 200014:12–32.
• Del Prete G, De Carli M, Almerigogna F, Giudizi MG, Biagiotti R, Romagnani S (1993). Human IL-10 is produced by both Type 1 helper (Th1) and Type 2 helper (Th2) T cell clones and inhibits their antigen-specific proliferation and cytokine production. J Immunol 150:353–360.[Abstract]
• Dennison DK, Van Dyke TE (1997). The acute inflammatory response and the role of phagocytic cells in periodontal health and disease. Periodontol 2000 14:54–78.[CrossRef]
• Deslauriers M, Haque S, Flood PM (1996). Identification of murine protective epitopes on the Porphyromonas gingivalis fimbrillin molecule. Infect Immun 64:434–440.[Abstract]
• Donaldson SL, Ranney RR, Burmeister JA, Tew JG (1982). Blastogenic responses by lymphocytes from periodontally healthy populations induced by periodontitis-associated bacteria. J Periodontol 53:743–751.[Medline] [Order article via Infotrieve]
• Donaldson SL, Ranney RR, Tew JG (1984). B-lymphocyte blastogenesis in response to periodontitis-associated bacteria. Kinetics and proportion of total response. J Periodontol 55:359–363.[Medline] [Order article via Infotrieve]
• Ebersole JL, Taubman MA (1994). The protective nature of host responses in periodontal diseases. Periodontol 2000 5:112–141.[CrossRef]
• Ebersole JL, Brunsvold M, Steffensen B, Wood R, Holt SC (1991). Effects of immunization with Porphyromonas gingivalis and Prevotella intermedia on progression of ligature-induced periodontitis in the nonhuman primate Macaca fascicularis. Infect Immun 59:3351–3359.[Abstract/Free Full Text]
• Ebersole JL, Cappelli D, Sandoval MN (1994). Subgingival distribution of A. actinomycetemcomitans in periodontitis. J Clin Periodontol 21:65–75.[CrossRef][Medline] [Order article via Infotrieve]
• Ebersole JL, Cappelli D, Sandoval MN, Steffen MJ (1995). Antigen specificity of serum antibody in A. actinomycetemcomitans-infected periodontitis patients. J Dent Res 74:658–666.[Abstract/Free Full Text]
• Ebersole JL, Feuille F, Kesavalu L, Holt SC (1997). Host modulation of tissue destruction caused by periodontopathogens: effects on a mixed microbial infection composed of Porphyromonas gingivalis and Fusobacterium nucleatum. Microb Pathog 23:23–32.[CrossRef][Medline] [Order article via Infotrieve]
• Engebretson SP, Lamster IB, Herrera-Abreu M, Celenti RS, Timms JM, Chaudhary AG, et al. (1999). The influence of interleukin gene polymorphism on expression of interleukin-1beta and tumor necrosis factor-alpha in periodontal tissue and gingival crevicular fluid. J Periodontol 70:567–573.[Medline] [Order article via Infotrieve]
• Engström PE, Larsson A, Norhagen G, Smith CI, Sallberg M, Helgeland K, et al. (1993). Specificity and levels of oral and systemic antibodies to Actinobacillus actinomycetemcomitans. J Clin Periodontol 20:746–751.[Medline] [Order article via Infotrieve]
• Engström PE, George M, Larsson P, Lally ET, Taichman NS, Norhagen G (1999). Oral and systemic immunoglobulin G-subclass antibodies to Actinobacillus actinomycetemcomitans leukotoxin. Oral Microbiol Immunol 14:104–108.[Medline] [Order article via Infotrieve]
• Essner R, Rhoades K, McBride WH, Morton DL, Economou JS (1989). IL-4 down-regulates IL-1 and TNF gene expression in human monocytes. J Immunol 142:3857–3861.[Abstract]
• Evans RI, Mikulecky M, Seymour GJ (1989). Effect of initial treatment of chronic inflammatory periodontal disease in adults on spontaneous peripheral blood lymphocyte proliferation. J Clin Periodontol 16:271–277.[CrossRef][Medline] [Order article via Infotrieve]
• Faddy MJ, Cullinan MP, Palmer JE, Westerman B, Seymour GJ (2000). Ante-dependence modeling in a longitudinal study of periodontal disease: the effect of age, gender and smoking status. J Periodontol 71:454–459.[Medline] [Order article via Infotrieve]
• Fives-Taylor P, Meyer D, Mintz K (1995). Characteristics of Actinobacillus actinomycetemcomitans invasion of and adhesion to cultured epithelial cells. Adv Dent Res 9:55–62.[Abstract/Free Full Text]
• Fujihashi K, Kono Y, Yamamoto M, McGhee JR, Beagley K, Aicher WK, et al. (1991). Interleukin production by gingival mononuclear cells isolated from adult periodontitis patients (abstract). J Dent Res 70(Spec Iss):550.
• Fujihashi K, Yamamoto M, McGhee JR, Kiyono H (1994). Type 1/Type 2 cytokine production by CD4+ T cells in adult periodontitis (abstract). J Dent Res 73(Spec Iss):204.
• Fujihashi K, Yamamoto M, Hiroi T, Bamberg TV, McGhee JR, Kiyono H (1996). Selected Th1 and Th2 cytokine mRNA expression by CD4(+) T cells isolated from inflamed human gingival tissues. Clin Exp Immunol 103:422–428.[CrossRef][Medline] [Order article via Infotrieve]
• Fujiwara T, Nishihara T, Koga T, Hamada S (1988). Serological properties and immunobiological activities of lipopolysaccharides from black-pigmented and related oral Bacteroides species. J Gen Microbiol 134(Pt 11):2867–2876.[Abstract/Free Full Text]
• Galbraith GM, Steed RB, Sanders JJ, Pandey JP (1998). Tumor necrosis factor alpha production by oral leukocytes: influence of tumor necrosis factor genotype. J Periodontol 69:428–433.[Medline] [Order article via Infotrieve]
• Gemmell E, Seymour GJ (1991). Phenotypic analysis of B-cells extracted from human periodontal disease tissue. Oral Microbiol Immunol 6:356–362.[Medline] [Order article via Infotrieve]
• Gemmell E, Seymour GJ (1992). Different responses in B cells induced by Porphyromonas gingivalis and Fusobacterium nucleatum. Arch Oral Biol 37:565–573.[CrossRef][Medline] [Order article via Infotrieve]
• Gemmell E, Seymour GJ (1994). Modulation of immune responses to periodontal bacteria. Curr Opin Periodont 94:28–38.
• Gemmell E, Seymour GJ (1998). Cytokine profiles of cells extracted from humans with periodontal diseases. J Dent Res 77:16–26.[Abstract/Free Full Text]
• Gemmell E, Feldner B, Seymour GJ (1992). CD45RA and CD45RO positive CD4 cells in human peripheral blood and periodontal disease tissue before and after stimulation with periodontopathic bacteria. Oral Microbiol Immunol 7:84–88.[Medline] [Order article via Infotrieve]
• Gemmell E, Walsh LJ, Savage NW, Seymour GJ (1994). Adhesion molecule expression in chronic inflammatory periodontal disease tissue. J Periodontal Res 29:46–53.[CrossRef][Medline] [Order article via Infotrieve]
• Gemmell E, Kjeldsen M, Yamazaki K, Nakajima T, Aldred MJ, Seymour GJ (1995). Cytokine profiles of Porphyromonas gingivalis-reactive T lymphocyte line and clones derived from P. gingivalis-infected subjects. Oral Dis 1:139–146.[Medline] [Order article via Infotrieve]
• Gemmell E, Winning TA, Bird PS, Seymour GJ (1998). Cytokine profiles of lesional and splenic T cells in Porphyromonas gingivalis infection in a murine model. J Periodontol 69:1131–1138.[Medline] [Order article via Infotrieve]
• Gemmell E, Grieco DA, Cullinan MP, Westerman B, Seymour GJ (1999). The proportion of interleukin-4, interferon-10-positive cells in Porphyromonas gingivalis-specific T-cell lines established from P. gingivalis-positive subjects. Oral Microbiol Immunol 14:267–274.[CrossRef][Medline] [Order article via Infotrieve]
• Gemmell E, Grieco DA, Seymour GJ (2000a). Chemokine expression in Porphyromonas gingivalis-specific T-cell lines. Oral Microbiol Immunol 15:166–171.[CrossRef][Medline] [Order article via Infotrieve]
• Gemmell E, Winning TA, Grieco DA, Bird PS, Seymour GJ (2000b). The influence of genetic variation on the splenic T cell cytokine and specific serum antibody responses in Porphyromonas gingivalis in mice. J Periodontol 71:1130–1138[CrossRef][Medline] [Order article via Infotrieve]
• Genco CA, Cutler CW, Kapczynski D, Maloney K, Arnold RR (1992). A novel mouse model to study the virulence of and host response to Porphyromonas (Bacteroides) gingivalis. Infect Immun 59:1255–1263.
• Gmür R, Hrodek K, Saxer UP, Guggenheim B (1986). Double-blind analysis of the relation between adult periodontitis and systemic host response to suspected periodontal pathogens. Infect Immun 52:768–776.[Abstract/Free Full Text]
• Gore EA, Sanders JJ, Pandey JP, Palesch Y, Galbraith GM (1998). Interleukin-1beta+3953 allele 2: association with disease status in adult periodontitis. J Clin Periodontol 25:781–785.[CrossRef][Medline] [Order article via Infotrieve]
• Graves DT, Delima AJ, Assuma R, Amar S, Oates T, Cochran D (1998). Interleukin-1 and tumor necrosis factor antagonists inhibit the progression of inflammatory cell infiltration toward alveolar bone in experimental periodontitis. J Periodontol 69:1419–1425.[Medline] [Order article via Infotrieve]
• Grossi SG, Zambon JJ, Ho AW, Koch G, Dunford RG, Machtei EE, et al. (1994). Assessment of risk for periodontal disease. I. Risk indicators for attachment loss. J Periodontol 65:260–267.[Medline] [Order article via Infotrieve]
• Grossi SG, Genco RJ, Machtei EE, Ho AW, Koch G, Dunford R, et al. E (1995). Assessment of risk for periodontal disease. II. Risk indicators for alveolar bone loss. J Periodontol 66:23–29.[Medline] [Order article via Infotrieve]
• Grossi SG, Skrepcinski FB, DeCaro T, Zambon JJ, Cummins D, Genco RJ (1996). Response to periodontal therapy in diabetics and smokers. J Periodontol 67(Suppl 10):1094–1102.[Medline] [Order article via Infotrieve]
• Hamilton RE Jr, Giansanti JS (1974). The Chediak-Higashi syndrome. Report of a case and review of the literature. Oral Surg Oral Med Oral Pathol 37:754–761.[CrossRef][Medline] [Order article via Infotrieve]
• Hart DN (1997). Dendritic cells: unique leukocyte populations which control the primary immune response. Blood 90:3245–3287.[Free Full Text]
• Hemmerle J, Frank RM (1991). Bacterial invasion of periodontal tissues after experimental immunosuppression in rats. J Biol Buccale 19:271–282.[Medline] [Order article via Infotrieve]
• Hirsch HZ, Tarkowski A, Miller EJ, Gay S, Koopman WJ, Mestecky J (1988). Autoimmunity to collagen in adult periodontal disease. J Oral Pathol 17:456–459.[CrossRef][Medline] [Order article via Infotrieve]
• Hotokezaka H, Hayashida H, Ohara N, Nomaguchi H, Kobayashi K, Yamada T (1994). Cloning and sequencing of the groEL homologue from Porphyromonas gingivalis. Biochim Biophys Acta 1219:175–178.[Medline] [Order article via Infotrieve]
• Inada K, Yoshida M, Sasaki O, Suzuki M, Yoshida H, Okuda K, et al. (1994). Polyclonal B cell activation, endotoxin tolerance, and limulus tests of endotoxin preparations of some periodontopathogens. Bull Tokyo Dent Coll 35:67–78.[Medline] [Order article via Infotrieve]
• Ishikawa I, Nakashima K, Koseki T, Nagasawa T, Watanabe H, Arakawa S, et al. (1997). Induction of the immune response to periodontopathic bacteria and its role in the pathogenesis of periodontitis. Periodontol 2000 14:79–111.[CrossRef]
• Isogai H, Isogai E, Fujii N, Oguma K, Kagota W, Takano K (1988). Histological changes and some in vitro biological activities induced by lipopolysaccharide from Bacteroides gingivalis. Zentralbl Bakteriol Mikrobiol Hyg A 269:64–77.
• Ito H, Harada Y, Matsuo T, Ebisu S, Okada H (1988). Possible role of T cells in the establishment of IgG plasma cell-rich periodontal lesion augmentation of IgG synthesis in the polyclonal B cell activation response by autoreactive T cells. J Periodontal Res 23:39–45.[CrossRef][Medline] [Order article via Infotrieve]
• Ivanyi L, Lehner T (1970). Stimulation of lymphocyte transformation by bacterial antigens in patients with periodontal disease. Arch Oral Biol 15:1089–1096.[CrossRef][Medline] [Order article via Infotrieve]
• Karatzas S, Novak MJ, Blieden TM (1996). Cytokine production by Porphyromonas gingivalis-specific human T cells (abstract). J Dent Res 75(Spec Iss):322.
• Katz J, Michalek SM (1998). Effect of immune T cells derived from mucosal or systemic tissue on host responses to Porphyromonas gingivalis. Oral Microbiol Immunol 13:73–80.[Medline] [Order article via Infotrieve]
• Kawai T, Eisen-Lev R, Seki M, Eastcott JW, Wilson ME, Taubman MA (2000). Requirement of B7 costimulation for Th1-mediated inflammatory bone resorption in experimental periodontal disease. J Immunol 164:2102–2109.[Abstract/Free Full Text]
• Kesavalu L, Ebersole JL, Machen RL, Holt SC (1992). Porphyromonas gingivalis virulence in mice: induction of immunity to bacterial components. Infect Immun 60:1455–1464.[Abstract/Free Full Text]
• Kinane DF, Mooney J, MacFarlane TW, McDonald M (1993). Local and systemic antibody response to putative periodontopathogens in patients with chronic periodontitis: correlation with clinical indices. Oral Microbiol Immunol 8:65–68.[Medline] [Order article via Infotrieve]
• Knight SC, Stagg AJ (1993). Antigen-presenting cell types. Curr Opin Immunol 5:374–382.[CrossRef][Medline] [Order article via Infotrieve]
• Kornman KS, Crane A, Wang HY, di Giovine FS, Newman MG, Pirk FW, et al. (1997). The interleukin-1 genotype as a severity factor in adult periodontal disease. J Clin Periodontol 24:72–77.[CrossRef][Medline] [Order article via Infotrieve]
• Kurihara H, Nishimura F, Nakamura T, Nakagawa M, Tanimoto I, Nomura Y, et al. (1991). Humoral immune response to an antigen from Porphyromonas gingivalis 381 in periodontal disease. Infect Immun 59:2758–2762.[Abstract/Free Full Text]
• Lamster IB, Kaluszhner-Shapira I, Herrera-Abreu M, Sinha R, Grbic JT (1998). Serum IgG antibody response to Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis: implications for periodontal diagnosis. J Clin Periodontol 25:510–516.[CrossRef][Medline] [Order article via Infotrieve]
• Lauener RP, Goyert SM, Geha RS, Vercelli D (1990). Interleukin 4 down-regulates the expression of CD14 in normal human monocytes. Eur J Immunol 20:2375–2381.[Medline] [Order article via Infotrieve]
• Lindhe J, Liljenberg B, Listgarten M (1980). Some microbiological and histopathological features of periodontal disease in man. J Periodontol 51:264–269.[Medline] [Order article via Infotrieve]
• Ling TY, Sims TJ, Chen HA, Whitney CW, Moncla BJ, Engel LD, et al. (1993). Titer and subclass distribution of serum IgG antibody reactive with Actinobacillus actinomycetemcomitans in localized juvenile periodontitis. J Clin Immunol 13:101–112.[CrossRef][Medline] [Order article via Infotrieve]
• Lloyd AR, Oppenheim JJ (1992). Poly's lament: the neglected role of the polymorphonuclear neutrophil in the afferent limb of the immune response. Immunol Today 13:169–172.[CrossRef][Medline] [Order article via Infotrieve]
• Lopatin DE, Blackburn E (1992). Avidity and titer of immunoglobulin G subclasses to Porphyromonas gingivalis in adult periodontitis patients. Oral Microbiol Immunol 7:332–337.[Medline] [Order article via Infotrieve]
• Lourbakos A, Chinni C, Thompson P, Potempa J, Travis J, Mackie EJ, et al. (1998). Cleavage and activation of proteinase-activated receptor-2 on human neutrophils by gingipain-R from Porphyromonas gingivalis. FEBS Lett 435:45–48.[CrossRef][Medline] [Order article via Infotrieve]
• Lynn WA, Golenbock DT (1992). Lipopolysaccharide antagonists. Immunol Today 13:271–276.[CrossRef][Medline] [Order article via Infotrieve]
• MacFarlane GD, Herzberg MC, Wolff LF, Hardie NA (1992). Refractory periodontitis associated with abnormal polymorphonuclear leukocyte phagocytosis and cigarette smoking. J Periodontol 63:908–913.[Medline] [Order article via Infotrieve]
• Mackler BF, Frostad KB, Robertson PB, Levy BM (1977). Immunoglobulin bearing lymphocytes and plasma cells in human periodontal disease. J Periodontal Res 12:37–45.[CrossRef][Medline] [Order article via Infotrieve]
• Madianos PN, Papapanou PN, Sandros J (1997). Porphyromonas gingivalis infection of oral epithelium inhibits neutrophil transepithelial migration. Infect Immun 65:3983–3990.[Abstract]
• Maeda H, Miyamoto M, Hongyo H, Nagai A, Kurihara H, Murayama Y (1994). Heat shock protein 60 (GroEL) from Porphyromonas gingivalis: molecular cloning and sequence analysis of its gene and purification of the recombinant protein. FEMS Microbiol Lett 119:129–136.[CrossRef][Medline] [Order article via Infotrieve]
• Mahanonda R, Seymour GJ, Powell LW, Good MF, Halliday JW (1991). Effect of initial treatment of chronic inflammatory periodontal disease on the frequency of peripheral blood T-lymphocytes specific to periodontopathic bacteria. Oral Microbiol Immunol 6:221–227.[Medline] [Order article via Infotrieve]
• Mangan DF, Won T, Lopatin DE (1983). Nonspecific induction of immunoglobulin M antibodies to periodontal disease-associated microorganisms after polyclonal human B-lymphocyte activation by Fusobacterium nucleatum. Infect Immun 41:1038–1045.[Abstract/Free Full Text]
• Mangan DF, Taichman NS, Lally ET, Wahl SM (1991). Lethal effects of Actinobacillus actinomycetemcomitans leukotoxin on human T lymphocytes. Infect Immun 59:3267–3272.[Abstract/Free Full Text]
• Manhart SS, Reinhardt RA, Payne JB, Seymour GJ, Gemmell E, Dyer JK, et al. (1994). Gingival cell IL-2 and IL-4 in early-onset periodontitis. J Periodontol 65:807–813.[Medline] [Order article via Infotrieve]
• Manus RM, Wilson AG, Mansfield J, Weir DG, Duff GW, Kelleher D (1996). TNF2, a polymorphism of the tumour necrosis-alpha gene promoter, is a component of the celiac disease major histocompatibility complex haplotype. Eur J Immunol 26:2113–2118.[Medline] [Order article via Infotrieve]
• Marcelletti JF (1996). IL-10 inhibits lipopolysaccharide-induced murine B cell proliferation and cross-linking of surface antigen receptors or ligation of CD40 restores the response. J Immunol 157:3323–3333.[Abstract]
• McGuire W, Hill AV, Allsopp CE, Greenwood BM, Kwiatkowski D (1994). Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria. Nature 371:508–510.[CrossRef][Medline] [Order article via Infotrieve]
• Meghji S, Henderson B, Wilson M (1993). Higher-titer antisera from patients with periodontal disease inhibit bacterial capsule-induced bone breakdown. J Periodontal Res 28:115–121.[CrossRef][Medline] [Order article via Infotrieve]
• Meghji S, Henderson B, Kirby A, Newman HN, Wilson M (1995). Serum antibody response to surface-associated material from periodontopathogenic bacteria. FEMS Immunol Med Microbiol 10:101–108.[CrossRef][Medline] [Order article via Infotrieve]
• Meng-HX, Zheng LF (1990). Langerhans cells in the gingival epithelium. Chung Hua Kou Chiang Hsueh Tsa Chih 25:146-8,189.
• Michalowicz BS (1994). Genetic and heritable risk factors in periodontal disease. J Periodontol 65(Suppl 5):479–488.[Medline] [Order article via Infotrieve]
• Michalowicz BS, Aeppli D, Virag JG, Klump DG, Hinrichs JE, Segal NL, et al. (1991). Periodontal findings in adult twins. J Periodontol 62:293–299.[Medline] [Order article via Infotrieve]
• Mooney J, Kinane DF (1994). Humoral immune responses to Porphyromonas gingivalis and Actinobacillus actinomycetemcomitans in adult periodontitis and rapidly progressive periodontitis. Oral Microbiol Immunol 9:321–326.[Medline] [Order article via Infotrieve]
• Mooney J, Kinane DF (1997). Levels of specific immunoglobulin G to Porphyromonas gingivalis in gingival crevicular fluid are related to site disease status. Oral Microbiol Immunol 12:112–116.[Medline] [Order article via Infotrieve]
• Mooney J, Adonogianaki E, Kinane DF (1993). Relative avidity of serum antibodies to putative periodontopathogens in periodontal disease. J Periodontal Res 28(6 Pt 1):444–450.[Medline] [Order article via Infotrieve]
• Moritz AJ, Cappelli D, Lantz MS, Holt SC, Ebersole JL (1998). Immunization with Porphyromonas gingivalis cysteine protease: effects on experimental gingivitis and ligature-induced periodontitis in Macaca fascicularis. J Periodontol 69:686–697.[Medline] [Order article via Infotrieve]
• Mosmann TR, Coffman RL (1989). TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Ann Rev Immunol 7:145–173.[CrossRef][Medline] [Order article via Infotrieve]
• Nakagawa S, Machida Y, Nakagawa T, Fujii H, Yamada S, Takazoe I, et al. (1994). Infection by Porphyromonas gingivalis and Actinobacillus actinomycetemcomitans, and antibody responses at different ages in humans. J Periodontal Res 29:9–16.[CrossRef][Medline] [Order article via Infotrieve]
• Nakajima T, Yamazaki K, Cullinan MP, Gemmell E, Seymour GJ (1999). T-cell antigen specificity in humans following stimulation with Porphyromonas gingivalis. Arch Oral Biol 44:1045–1053.[CrossRef][Medline] [Order article via Infotrieve]
• Nakano Y, Inai Y, Yamashita Y, Nagaoka S, Kusuzaki Nagira T, Nishihara T, et al. (1995). Molecular and immunological characterization of a 64-kDa protein of Actinobacillus actinomycetemcomitans. Oral Microbiol Immunol 10:151–159.[Medline] [Order article via Infotrieve]
• Nickoloff BJ, Turka LA (1994). Immunological functions of non-professional antigen-presenting cells: new insights from studies of T-cell interactions with keratinocytes. Immunol Today 15:464–469.[CrossRef][Medline] [Order article via Infotrieve]
• Nickoloff BJ, Mitra RS, Green J, Zheng XG, Shimizu Y, Thompson C, et al. (1993). Accessory cell function of keratinocytes for superantigens. Dependence on lymphocyte function-associated antigen-1/intercellular adhesion molecule-1 interaction. J Immunol 150:2148–2159.[Abstract]
• Offenbacher S (1996). Periodontal diseases: pathogenesis. Ann Periodontol 1:821–878.[Medline] [Order article via Infotrieve]
• Okada H, Ito H, Harada Y (1987). T-cell requirement for establishment of the IgG-dominant B-cell lesion in periodontitis. J Periodontal Res 22:187–189.[Medline] [Order article via Infotrieve]
• Okada H, Shimabukuro Y, Kassai Y, Ito H, Matsuo T, Ebisu S, et al. (1988). The function of gingival lymphocytes on the establishment of human periodontitis. Adv Dent Res 2:364–367.[Abstract/Free Full Text]
• Oldstone MBA (1987). Molecular mimicry and autoimmune disease. Cell 50:819–820.[CrossRef][Medline] [Order article via Infotrieve]
• Oshikiri K, Kawamura I, Hara K, Mitsuyama M (1994). Specific immune response to the 40-kDa outer-membrane protein of Porphyromonas gingivalis in mice. Arch Oral Biol 39:707–713.[CrossRef][Medline] [Order article via Infotrieve]
• Page RC, Schroeder HE (1976). Pathogenesis of inflammatory periodontal disease. A summary of current work. Lab Invest 34:235–249.[Medline] [Order article via Infotrieve]
• Page RC, Offenbacher S, Schroeder HE, Seymour GJ, Kornman KS (1997). Advances in the pathogenesis of periodontitis: summary of developments, clinical implication and future directions. Periodontol 2000 14:216–248.[CrossRef]
• Persson GR, Engel D, Whitney C, Darveau R, Weinberg A, Brunsvold M, et al. (1994). Immunization against Porphyromonas gingivalis inhibits progression of experimental periodontitis in nonhuman primates. Infect Immun 62:1026–1031.[Abstract/Free Full Text]
• Pettit AR, Thomas R (1999). Dendritic cells: the driving force behind autoimmunity in rheumatoid arthritis. Immunol Cell Biol 77:420–427.[CrossRef][Medline] [Order article via Infotrieve]
• Pietrzak ER, Polak B, Walsh LJ, Savage NW, Seymour GJ (1998). Characterization of serum antibodies to Porphyromonas gingivalis in individuals with and without periodontitis. Oral Microbiol Immunol 13:65–72.[Medline] [Order article via Infotrieve]
• Pilon M, Williams-Miller C, Cox DS (1991). Interleukin-2 levels in gingival crevicular fluid in periodontitis (abstract). J Dent Res 70(Spec Iss):550.
• Polak B, Vance JB, Dyer JK, Bird PS, Gemmell E, Reinhardt RA, et al. (1995). IgG antibody subclass response to Porphyromonas gingivalis outer membrane antigens in gingivitis and adult periodontitis. J Periodontol 66:363–368.[Medline] [Order article via Infotrieve]
• Poulter LW, Seymour GJ, Duke O, Janossy G, Panayi G (1982). Immunohistological analysis of delayed-type hypersensitivity in man. Cell Immunol 74:358–369.[CrossRef][Medline] [Order article via Infotrieve]
• Prabhu A, Michalowicz BS, Mathur A (1996). Detection of local and systemic cytokines in adult periodontitis. J Periodontol 67:515–522.[Medline] [Order article via Infotrieve]
• Reinhardt RA, Bolton RW, McDonald TL, DuBois LM, Kaldahl WB (1988). In situ lymphocyte subpopulations from active versus stable periodontal sites. J Periodontol 59:656–670.[Medline] [Order article via Infotrieve]
• Reinhardt RA, McDonald TL, Bolton RW, Dubois LM, Kaldahl WB (1989). IgG subclasses in gingival crevicular fluid from active versus stable periodontal sites. J Periodontol 60:44–50.[Medline] [Order article via Infotrieve]
• Rescigno M, Granucci F, Ricciardi-Castagnoli P (1999). Dendritic cells at the end of the millennium. Immunol Cell Biol 77:404–410.[CrossRef][Medline] [Order article via Infotrieve]
• Saglie FR, Marfany A, Camargo P (1988). Intragingival occurrence of Actinobacillus actinomycetemcomitans and Bacteroides gingivalis in active destructive periodontal lesions. J Periodontol 59:259–265.[Medline] [Order article via Infotrieve]
• Saito A, Hosaka Y, Nakagawa T, Seida K, Yamada S, Takazoe I, et al. (1993). Significance of serum antibody against surface antigens of Actinobacillus actinomycetemcomitans in patients with adult periodontitis. Oral Microbiol Immunol 8:146–153.[Medline] [Order article via Infotrieve]
• Salvi GE, Brown CE, Fujihashi K, Kiyono H, Smith FW, Beck JD, et al. (1998). Inflammatory mediators of the terminal dentition in adult and early onset periodontitis. J Periodontal Res 33:212–225.[CrossRef][Medline] [Order article via Infotrieve]
• Sanders LA, van de Winkel JG, Rijkers GT, Voorhorst Ogink MM, de Haas M, Capel PJ, et al. (1994). Fc gamma receptor IIa (CD32) heterogeneity in patients with recurrent bacterial respiratory tract infections. J Infect Dis 170:854–861.[Medline] [Order article via Infotrieve]
• Sanders LA, Feldman RG, Voorhorst Ogink MM, de Haas M, Rijkers GT, Capel PJ, et al. (1995). Human immunoglobulin G (IgG) Fc receptor IIA (CD32) polymorphism and IgG2-mediated bacterial phagocytosis by neutrophils. Infect Immun 63:73–81.[Abstract]
• Sandros J, Papapanou P, Dahlén G (1993). Porphyromonas gingivalis invades oral epithelial cells in vitro. J Periodontal Res 28:219–226.[CrossRef][Medline] [Order article via Infotrieve]
• Schenkein HA (1988). The effect of periodontal proteolytic Bacteroides species on proteins of the human complement system. J Periodontal Res 23:187–192.[CrossRef][Medline] [Order article via Infotrieve]
• Schenkein HA, Fletcher HM, Bodnar M, Macrina FL (1995). Increased opsonization of a prtH-defective mutant of Porphyromonas gingivalis W83 is caused by reduced degradation of complement-derived opsonins. J Immunol 154:5331–5337.[Abstract]
• Schreiber S, Heinig T, Thiele HG, Raedler A (1995). Immunoregulatory role of interleukin 10 in patients with inflammatory bowel disease. Gastroenterology 108:1434–1444.[CrossRef][Medline] [Order article via Infotrieve]
• Scott P (1993). Selective differentiation of CD4+ T helper cell subsets. Curr Opin Immunol 5:391–397.[CrossRef][Medline] [Order article via Infotrieve]
• Seymour GJ, Greenspan JS (1979). The phenotypic characterization of lymphocyte subpopulations in established human periodontal disease. J Periodontal Res 14:39–46.[CrossRef][Medline] [Order article via Infotrieve]
• Seymour GJ, Powell RN, Davies WI (1979). Conversion of a stable T-cell lesion to a progressive B-cell lesion in the pathogenesis of chronic inflammatory periodontal disease: an hypothesis. J Clin Periodontol 6:267–277.[Medline] [Order article via Infotrieve]
• Seymour GJ, Powell RN, Aitken JF (1983). Experimental gingivitis in humans. A clinical and histologic investigation. J Periodontol 54:522–528.[Medline] [Order article via Infotrieve]
• Seymour GJ, Gemmell E, Walsh LJ, Powell RN (1988). Immunohistological analysis of experimental gingivitis in humans. Clin Exp Immunol 71:132–137.[Medline] [Order article via Infotrieve]
• Seymour GJ, Gemmell E, Reinhardt RA, Eastcott J, Taubman MA (1993). Immunopathogenesis of chronic inflammatory periodontal disease: cellular and molecular mechanisms. J Periodontal Res 28:478–486.[CrossRef][Medline] [Order article via Infotrieve]
• Shapira L, van Dyke TE, Hart TC (1992). A localized absence of interleukin-4 triggers periodontal disease activity: a novel hypothesis. Med Hypotheses 39:319–322.[CrossRef][Medline] [Order article via Infotrieve]
• Shapira L, Takashiba S, Amar S, Van Dyke TE (1994). Porphyromonas gingivalis lipopolysaccharide stimulation of human monocytes: dependence on serum and CD14 receptor. Oral Microbiol Immunol 9:112–117.[Medline] [Order article via Infotrieve]
• Shenker BJ, Slots J (1989). Immunomodulatory effects of Bacteroides products on in vitro human lymphocyte functions. Oral Microbiol Immunol 4:24–29.[Medline] [Order article via Infotrieve]
• Shenker BJ, McArthur WP, Tsai CC (1982a). Immune suppression induced by Actinobacillus actinomycetemcomitans. I. Effects on human peripheral blood lymphocyte responses to mitogens and antigens. J Immunol 128:148–154.[Medline] [Order article via Infotrieve]
• Shenker BJ, Tsai CC, Taichman NS (1982b). Suppression of lymphocyte responses by Actinobacillus actinomycetemcomitans. J Periodontal Res 17:462–465.[CrossRef][Medline] [Order article via Infotrieve]
• Sigusch B, Klinger G, Glockmann E, Simon HU (1998). Early-onset and adult periodontitis associated with abnormal cytokine production by activated T lymphocytes. J Periodontol 69:1098–1104.[Medline] [Order article via Infotrieve]
• Slots J (1999). Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis in periodontal disease: introduction. Periodontol 2000 20:7–13.
• Springer TA, Thompson WS, Miller LJ, Schmalstieg FC, Anderson DC (1984). Inherited deficiency of the Mac-1, LFA-1, p150,95 glycoprotein family and its molecular basis. J Exp Med 160:1901–1918.[Abstract/Free Full Text]
• Stashenko P, Resmini LM, Haffajee AD, Socransky SS (1983). T cell responses of periodontal disease patients and healthy subjects to oral microorganisms. J Periodontal Res 18:587–600.[CrossRef][Medline] [Order article via Infotrieve]
• Stein SH, Hendrix CL (1996). Interleukin-10 promotes anti-collagen antibody production in gingival mononuclear cells (abstract). J Dent Res 75(Spec Iss):158.
• Steinman RM (1991). The dendritic cell system and its role in immunogenicity. Annu Rev Immunol 9:271–296.[CrossRef][Medline] [Order article via Infotrieve]
• Stoufi ED, Taubman MA, Ebersole JL, Smith DJ, Stashenko PP (1987). Phenotypic analyses of mononuclear cells recovered from healthy and diseased human periodontal tissues. J Clin Immunol 7:235–245.[CrossRef][Medline] [Order article via Infotrieve]
• Suchett-Kaye G, Morrier J-J, Barsotti O (1998). Interactions between non-immune host cells and the immune system during periodontal disease: role of the gingival keratinocyte. Crit Rev Oral Biol Med 9:292–305.[Abstract/Free Full Text]
• Sugawara M, Yamahita K, Yoshie H, Hara K (1992). Detection of, and anti-collagen antibody produced by, CD5-positive B cells in inflamed gingival tissues. J Periodontal Res 27:489–498.[Medline] [Order article via Infotrieve]
• Sundqvist GK, Carlsson J, Herrmann BF, Hofling JF, Vaatainen A (1984Degradation in vivo of the C3 protein of guinea-pig complement by a pathogenic strain of Bacteroides gingivalis. Scand J Dent Res 92:14–24.[Medline] [Order article via Infotrieve]
• Sundstrom JB, Ansari AA (1995). Comparative study of the role of professional versus semiprofessional or nonprofessional antigen presenting cells in the rejection of vascularized organ allografts. Transpl Immunol 3:273–289.[CrossRef][Medline] [Order article via Infotrieve]
• Tabeta K, Yamazaki K, Hotokezaka H, Yoshie H, Hara K (2000). Elevated humoral immune response to heat shock protein 60 family in periodontitis patients. Clin Exp Immunol 120:285–293.[CrossRef][Medline] [Order article via Infotrieve]
• Taichman NS, Dean RT, Sanderson CJ (1980). Biochemical and morphological characterization of the killing of human monocytes by a leukotoxin derived from Actinobacillus actinomycetemcomitans. Infect Immun 28:258–268.[Abstract/Free Full Text]
• Taichman NS, Iwase M, Lally ET, Shattil SJ, Cunningham ME, Korchak HM (1991). Early changes in cytosolic calcium and membrane potential induced by Actinobacillus actinomycetemcomitans leukotoxin in susceptible and resistant target cells. J Immunol 147:3587–3594.[Abstract]
• Takahashi K, Lappin D, Kinane DF (1996). In situ localization of cell synthesis and proliferation in periodontitis gingiva and tonsillar tissue. Oral Dis 2:210–216.[Medline] [Order article via Infotrieve]
• Takeichi O, Taubman MA, Haber J, Smith DJ, Moro I (1994). Cytokine profiles of CD4 and CD8 T cells isolated from adult periodontitis gingivae (abstract). J Dent Res 73(Spec Iss):205.
• Takeuchi Y, Yoshie H, Hara K (1991). Expression of interleukin-2 receptor and HLA-DR on lymphocyte subsets of gingival crevicular fluid in patients with periodontitis. J Periodontal Res 26:502–510.[Medline] [Order article via Infotrieve]
• Taubman MA, Stoufi ED, Ebersole JL, Smith DJ (1984a). Phenotypic studies of cells from periodontal disease tissue. J Periodont Res 19:587–590.[CrossRef][Medline] [Order article via Infotrieve]
• Taubman MA, Yoshie H, Ebersole JL, Smith DJ, Olson CL (1984b). Host response in experimental periodontal disease. J Dent Res 63:455–460.[Abstract/Free Full Text]
• Taubman MA, Haffajee AD, Socransky SS, Smith DJ, Ebersole JL (1992). Longitudinal monitoring of humoral antibody in subjects with destructive periodontal diseases. J Periodontal Res 27:511–521.[CrossRef][Medline] [Order article via Infotrieve]
• Te Velde AA, Huijbens RJ, Heije K, de Vries JE, Figdor CG (1990). Interleukin-4 (IL-4) inhibits secretion of IL-1 beta, tumor necrosis factor alpha, and IL-6 by human monocytes. Blood 76:1392–1397.[Abstract/Free Full Text]
• Tokoro Y, Matsuki Y, Yamamoto T, Suzuki T, Hara K (1997). Relevance of local Th2-type cytokine mRNA expression in immunocompetent infiltrates in inflamed gingival tissue to periodontal diseases. Clin Exp Immunol 107:166–174.[CrossRef][Medline] [Order article via Infotrieve]
• Trinchieri G (1997). Cytokines acting on or secreted by macrophages during intracellular infection (IL-10, IL-12, IFN-). Curr Opin Immunol 9:17–23.[Medline] [Order article via Infotrieve]
• Tsai CC, McArthur WP, Baehni PC, Evian C, Genco RJ, Taichman NS (1981). Serum neutralizing activity against Actinobacillus actinomycetemcomitans leukotoxin in juvenile periodontitis. J Clin Periodontol 8:338–348.[CrossRef][Medline] [Order article via Infotrieve]
• Ukai T, Hara Y, Kato I (1996). Effects of T cell adoptive transfer into nude mice on alveolar bone resorption induced by endotoxin. J Periodontal Res 31:414–422.[CrossRef][Medline] [Order article via Infotrieve]
• Underwood K, Sjöstrom K, Darveau R, Lamont R, Schenkein H, Gunsolley J, et al. (1993). Serum antibody opsonic activity against Actinobacillus actinomycetemcomitans in human periodontal diseases. J Infect Dis 168:1436–1443.[Medline] [Order article via Infotrieve]
• Waldrop TC, Anderson DC, Hallmon WW, Schmalstieg FC, Jacob RL (1987). Periodontal manifestations of the heritable Mac-1, LFA-1, deficiency syndrome. Clinical, histopathologic and molecular characteristics. J Periodontol 58:400–416.[Medline] [Order article via Infotrieve]
• Wang H, Taubman MA, Smith DJ (1989). Effect of depletion of CD8+ T cells on immunoglobulin synthesis by gingival lymphocytes (abstract). J Dent Res 68(Spec Iss):221.
• Wassenaar A, Reinhardus C, Thepen T, Abraham Inpijn L, Kievits F (1995). Cloning, characterization, and antigen specificity of T-lymphocyte subsets extracted from gingival tissue of chronic adult periodontitis patients. Infect Immun 63:2147–2153.[Abstract]
• Wassenaar A, Reinhardus C, Abraham Inpijn L, Kievits F (1996). Type-1 and type-2 CD8+ T-cell subsets isolated from chronic adult periodontitis tissue differ in surface phenotype and biological functions. Immunology 87:113–118.[Medline] [Order article via Infotrieve]
• Watanabe K, Kumada H, Yoshimura F, Umemoto T (1996). The induction of polyclonal B-cell activation and interleukin-1 production by the 75-kDa cell surface protein from Porphyromonas gingivalis in mice. Arch Oral Biol 41:725–731.[CrossRef][Medline] [Order article via Infotrieve]
• Weinstein SL, June CH, DeFranco AL (1993). Lipopolysaccharide-induced protein tyrosine phosphorylation in human macrophages is mediated by CD14. J Immunol 151:3829–3838.[Abstract]
• Wheeler TT, McArthur WP, Magnusson I, Marks RG, Smith J, Sarrett DC, et al. (1994). Modeling the relationship between clinical, microbiologic, and immunologic parameters and alveolar bone levels in an elderly population. J Periodontol 65:68–78.[Medline] [Order article via Infotrieve]
• Whitney C, Ant J, Moncla B, Johnson B, Page RC, Engel D (1992). Serum immunoglobulin G antibody to Porphyromonas gingivalis in rapidly progressive periodontitis: titer, avidity, and subclass distribution. Infect Immun 60:2194–2200.[Abstract/Free Full Text]
• Wilson AG, di Giovine FS, Duff GW (1995). Genetics of tumour necrosis factor-alpha in autoimmune, infectious, and neoplastic diseases. J Inflamm 45:1–12.[Medline] [Order article via Infotrieve]
• Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW (1997). Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci USA 94:3195–3199.[Abstract/Free Full Text]
• Wilton JM, Hurst TJ, Sterne JA (1993). Elevated opsonic activity for Porphyromonas (Bacteroides) gingivalis in serum from patients with a history of destructive periodontal disease. A case:control study. J Clin Periodontol 20:563–569.[CrossRef][Medline] [Order article via Infotrieve]
• Wright SD, Ramos RA, Tobias PS, Ulevitch RJ, Mathison JC (1990). CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 249:1431–1433.[Abstract/Free Full Text]
• Yamamoto M, Kawabata K, Fujihashi K, McGhee JR, Van Dyke TE, Bamberg TV, et al. (1996). Absence of exogenous interleukin-4-induced apoptosis of gingival macrophages may contribute to chronic inflammation in periodontal diseases. Am J Pathol 148:331–339.[Abstract]
• Yamamoto M, Fujihashi K, Hiroi T, McGhee JR, Van Dyke TE, Kiyono H (1997). Molecular and cellular mechanisms for periodontal diseases: role of Th1 and Th2 type cytokines in induction of mucosal inflammation. J Periodontal Res 32:115–119.[CrossRef][Medline] [Order article via Infotrieve]
• Yamashita K, Eastcott JW, Taubman MA, Smith DJ, Cox DS (1991). Effect of adoptive transfer of cloned Actinobacillus actinomycetemcomitans-specific T helper cells on periodontal disease. Infect Immun 59:1529–1534.[Abstract/Free Full Text]
• Yamazaki K, Polak B, Bird PS, Gemmell E, Hara K, Seymour GJ (1989). Effects of periodontopathic bacteria on IL-1 and IL-1 inhibitor production by human polymorphonuclear neutrophils. Oral Microbiol Immunol 4:193–198.[Medline] [Order article via Infotrieve]
• Yamazaki K, Nakajima T, Aoyagi T, Hara K (1993). Immunohistological analysis of memory T lymphocytes and activated B lymphocytes in tissues with periodontal disease. J Periodontal Res 28:324–334.[CrossRef][Medline] [Order article via Infotrieve]
• Yamazaki K, Nakajima T, Aoyagi T, Hara K (1994a). Immunohistological analysis of memory T lymphocytes and activated B lymphocytes in tissues with periodontal disease. J Periodontal Res 28:324–334.
• Yamazaki K, Nakajima T, Gemmell E, Polak B, Seymour GJ, Hara K (1994b). IL-4- and IL-6-producing cells in human periodontal disease tissue. J Oral Pathol Med 23:347–353.[CrossRef][Medline] [Order article via Infotrieve]
• Yamazaki K, Nakajima T, Kubota Y, Gemmell E, Seymour GJ, Hara K (1997). Cytokine messenger RNA expression in chronic inflammatory periodontal disease. Oral Microbiol Immunol 12:281–287.[Medline] [Order article via Infotrieve]
• Zadeh HH, Nichols FC, Miyasaki KT (1999). The role of the cell-mediated immune response to Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis in periodontitis. Periodontol 2000 20:239–288.

Critical Reviews in Oral Biology & Medicine, Vol. 13, No. 1, 17-34 (2002)
DOI: 10.1177/154411130201300104


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				J. C. Galicia, M. R. Benakanakere, P. G. Stathopoulou, and D. F. Kinane Neutrophils rescue gingival epithelial cells from bacterial-induced apoptosis J. Leukoc. Biol., July 1, 2009; 86(1): 181 - 186. [Abstract] [Full Text] [PDF]

				S.L. Gaffen and G. Hajishengallis A New Inflammatory Cytokine on the Block: Re-thinking Periodontal Disease and the Th1/Th2 Paradigm in the Context of Th17 Cells and IL-17 Journal of Dental Research, September 1, 2008; 87(9): 817 - 828. [Abstract] [Full Text] [PDF]

				G. d'Empaire, M. T. Baer, and F. C. Gibson III The K1 Serotype Capsular Polysaccharide of Porphyromonas gingivalis Elicits Chemokine Production from Murine Macrophages That Facilitates Cell Migration Infect. Immun., November 1, 2006; 74(11): 6236 - 6243. [Abstract] [Full Text] [PDF]

				Y.-T.A. Teng Protective and Destructive Immunity in the Periodontium: Part 2--T-cell-mediated Immunity in the Periodontium Journal of Dental Research, March 1, 2006; 85(3): 209 - 219. [Abstract] [Full Text] [PDF]

				P.N.R. Nair PATHOGENESIS OF APICAL PERIODONTITIS AND THE CAUSES OF ENDODONTIC FAILURES Critical Reviews in Oral Biology & Medicine, November 1, 2004; 15(6): 348 - 381. [Abstract] [Full Text] [PDF]

				E. Gemmell, C.L. Carter, and G.J. Seymour Mast Cells in Human Periodontal Disease Journal of Dental Research, May 1, 2004; 83(5): 384 - 387. [Abstract] [Full Text] [PDF]

				R. Jotwani and C. W. Cutler Fimbriated Porphyromonas gingivalis Is More Efficient than Fimbria-Deficient P. gingivalis in Entering Human Dendritic Cells In Vitro and Induces an Inflammatory Th1 Effector Response Infect. Immun., March 1, 2004; 72(3): 1725 - 1732. [Abstract] [Full Text] [PDF]

				K. Moen, J. G. Brun, T. M. Madland, T. Tynning, and R. Jonsson Immunoglobulin G and A Antibody Responses to Bacteroides forsythus and Prevotella intermedia in Sera and Synovial Fluids of Arthritis Patients Clin. Vaccine Immunol., November 1, 2003; 10(6): 1043 - 1050. [Abstract] [Full Text] [PDF]

				A. A. DeCarlo, Y. Huang, C. A. Collyer, D. B. Langley, and J. Katz Feasibility of an HA2 Domain-Based Periodontitis Vaccine Infect. Immun., January 1, 2003; 71(1): 562 - 566. [Abstract] [Full Text] [PDF]

This Article Abstract Figures Only Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Gemmell, E. Articles by Seymour, G.J. Search for Related Content PubMed PubMed Citation Social Bookmarking                         What's this?